WO2022089458A1 - Expression regulatory element and use thereof - Google Patents

Expression regulatory element and use thereof Download PDF

Info

Publication number
WO2022089458A1
WO2022089458A1 PCT/CN2021/126562 CN2021126562W WO2022089458A1 WO 2022089458 A1 WO2022089458 A1 WO 2022089458A1 CN 2021126562 W CN2021126562 W CN 2021126562W WO 2022089458 A1 WO2022089458 A1 WO 2022089458A1
Authority
WO
WIPO (PCT)
Prior art keywords
seq
expression
control element
target gene
plant
Prior art date
Application number
PCT/CN2021/126562
Other languages
French (fr)
Chinese (zh)
Inventor
解光宁
牛小牧
梁亚峰
Original Assignee
山东舜丰生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 山东舜丰生物科技有限公司 filed Critical 山东舜丰生物科技有限公司
Publication of WO2022089458A1 publication Critical patent/WO2022089458A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells

Definitions

  • the invention belongs to the field of biotechnology, and in particular relates to an expression control element and its application in regulating gene expression.
  • a cis-acting element refers to a specific DNA sequence in series with a structural gene, which is the binding site of a transcription factor and regulates gene transcription by binding to a transcription factor.
  • a cis-element that enhances transcription upon binding to a transcription factor is called an enhancer.
  • the OCS gene encodes octopine synthase in Agrobacterium, and its promoter part has TATA box and CAAT box similar to eukaryotic promoters, which can be ubiquitously expressed in plant cells and has the characteristics of plant promoters.
  • TATA box and CAAT box similar to eukaryotic promoters, which can be ubiquitously expressed in plant cells and has the characteristics of plant promoters.
  • ACGTAAGCGCTTACGT 16bp palindromic sequence
  • the purpose of the present invention is to provide an expression control element and its application.
  • the present invention designs 64 expression control elements to be screened, connects to the expression vector for screening, and obtains 19 kinds of expression control elements with enhanced functions. These 19 kinds of expression control elements can improve the level of gene expression. have a significant effect.
  • the present invention provides an expression control element comprising the nucleotide sequence shown in any of SEQ ID NO.: 1-64 or a nucleotide sequence complementary thereto.
  • the expression control element comprises SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.:8, SEQ ID NO.:10, SEQ ID NO. .:12, SEQ ID NO.:17, SEQ ID NO.:20, SEQ ID NO.:23, SEQ ID NO.:24, SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO.
  • Polynucleotide sequence preferably, the polynucleotide shown in any of SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO.:44, SEQ ID NO.:45 or SEQ ID NO.:48 sequence.
  • the expression control element is SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.:8, SEQ ID NO.:10, SEQ ID NO. .:12, SEQ ID NO.:17, SEQ ID NO.:20, SEQ ID NO.:23, SEQ ID NO.:24, SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO.
  • Polynucleotide sequence preferably, the polynucleotide shown in any of SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO.:44, SEQ ID NO.:45 or SEQ ID NO.:48 sequence.
  • the expression regulatory element is associated with SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.:8, SEQ ID NO.:10, SEQ ID NO. .:12, SEQ ID NO.:17, SEQ ID NO.:20, SEQ ID NO.:23, SEQ ID NO.:24, SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO.
  • the expression control element is the same as SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.:8, SEQ ID NO.:10, SEQ ID NO.:10, SEQ ID NO. NO.:10, SEQ ID NO. NO.:12, SEQ ID NO.:17, SEQ ID NO.:20, SEQ ID NO.:23, SEQ ID NO.:24, SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO .:43, SEQ ID NO.:44, SEQ ID NO.:45, SEQ ID NO.:48, SEQ ID NO.:49, SEQ ID NO.:51 or SEQ ID NO.:55 sequence-complementary polynucleotides.
  • the polynucleotide is preferably single-stranded or double-stranded.
  • the present invention provides a nucleic acid construct comprising the aforementioned expression regulatory element and a regulatory element or target gene operably linked thereto.
  • the regulatory element is selected from one or more of the group consisting of promoter, enhancer, intron, 5'-untranslated region (5'-UTR, also known as leader sequence), 3'-UTR, transposon, terminator, polyadenylation sequence, marker gene, or a combination thereof.
  • the gene of interest comprises herbicide tolerance, insect resistance, disease resistance, abiotic stress tolerance, yield stability, increased yield, carbohydrate metabolism, fatty acid metabolism, amino acid metabolism , Plant development, plant growth regulation, drought resistance, cold resistance, heat resistance, nutrient use efficiency, nitrogen use efficiency and salt resistance genes, microRNAs (small RNAs) and small RNA precursors.
  • the present invention also provides a vector, which contains the above-mentioned expression control element and/or nucleic acid construct, preferably, the vector further includes a regulatory element operably linked to the above-mentioned expression control element and/or nucleic acid construct or target gene.
  • the target gene is selected from plant genes or non-plant genes, and the non-plant genes include genes derived from eukaryotes or prokaryotes.
  • the gene of interest comprises herbicide tolerance, insect resistance, disease resistance, abiotic stress tolerance, yield stability, increased yield, carbohydrate metabolism, fatty acid metabolism, amino acid metabolism , Plant development, plant growth regulation, drought resistance, cold resistance, heat resistance, nutrient use efficiency, nitrogen use efficiency and salt resistance genes, microRNA (small RNA) and small RNA precursors.
  • the vectors include cloning vectors, expression vectors, shuttle vectors, and integration vectors.
  • the expression vector further contains at least one origin of replication to achieve self-replication.
  • the vector may be one that, when introduced into a host cell, is integrated into the genome and replicated together with the chromosome into which it is integrated.
  • Vectors can be of the type plasmid, virus, cosmid, phage, etc., which are well known to those skilled in the art.
  • the vector in the present invention is a plasmid.
  • the present invention provides a host cell containing one or more of the aforementioned expression control elements, nucleic acid constructs and vectors.
  • the aforementioned expression control element is integrated into the genome of the host cell.
  • the host cell is a prokaryotic cell, such as Escherichia coli, Agrobacterium.
  • the host cells are eukaryotic cells, including animal cells, plant cells, fungi, etc.; preferably, the eukaryotic cells are plant cells, and preferably, the plants include angiosperms and gymnosperms .
  • the plants include monocotyledonous and dicotyledonous plants.
  • the plants include herbaceous and woody plants.
  • the plant comprises Arabidopsis, tobacco, rice, corn, sorghum, barley, wheat, millet, soybean, tomato, potato, quinoa, lettuce, canola, cabbage, strawberry.
  • the present invention also provides a plant stably transformed by a vector, wherein the vector contains the expression control element of the present invention; preferably, the vector includes the expression control element of the present invention and a target gene.
  • the present invention also provides a plant with increased expression of a target gene, wherein the regulatory region of the target gene comprises the expression control element of the present invention.
  • the expression control element can be obtained by changing one or more nucleotides in the regulatory region of the target gene, or can be introduced by gene editing, or inserted into the regulatory region of the target gene. Expression regulatory elements are obtained.
  • the present invention also provides a method for regulating the expression of a target gene, the method comprising the step of regulating the expression of the target gene using the expression control element of the present invention.
  • the regulation of target gene expression is to increase target gene expression.
  • the target gene may be an endogenous gene or an exogenous gene relative to the host cell.
  • the gene of interest comprises herbicide tolerance, insect resistance, disease resistance, abiotic stress tolerance, yield stability, increased yield, carbohydrate metabolism, fatty acid metabolism, amino acid metabolism , Plant development, plant growth regulation, drought resistance, cold resistance, heat resistance, nutrient use efficiency, nitrogen use efficiency and salt resistance genes, microRNA (small RNA) and small RNA precursors.
  • the method for regulating a target gene target comprises the step of introducing the expression control element of the present invention into the regulatory region of the target gene.
  • regulatory region generally refers to regulatory elements, such as promoters, enhancers, introns, 5'-untranslated regions (5'- UTR, also known as leader sequence) or 3'-UTR, transposon, region where terminator is located, or other non-coding region.
  • regulatory elements such as promoters, enhancers, introns, 5'-untranslated regions (5'- UTR, also known as leader sequence) or 3'-UTR, transposon, region where terminator is located, or other non-coding region.
  • the regulatory region is the region where the promoter is located or upstream of the promoter.
  • the introduction of the expression regulatory element of the present invention into the regulatory region of the target gene can be achieved by the following manner: by editing one or more nucleic acids in the regulatory region of the target gene, the regulatory region includes the expression regulatory element of the present invention Alternatively, the expression regulatory element of the present invention is inserted into the regulatory region of the target gene so that the regulatory region includes the expression regulatory element of the present invention.
  • the editing includes changes, deletions, insertions and the like to nucleic acids.
  • the expression regulatory element of the present invention is introduced into the regulatory region of the target gene, which can be achieved by homologous recombination, gene editing (eg, CRISPR technology, TALEN technology, ZFN technology).
  • the method comprises inserting at least 1 copy of the expression regulatory element of the invention into the regulatory region of the gene of interest.
  • the expression control element is set within 0-5000bp upstream or downstream of the transcription initiation site of the target gene, preferably within 0-2000bp, preferably within 0-550bp, preferably within 0-550bp Within 0-200bp.
  • the expression control element is upstream or downstream of the transcription initiation site.
  • the expression control element is set in the promoter region; preferably, it is set in the upstream 1bp-200bp of the TATA box in the promoter region, more preferably, 20bp-100bp, more preferably, 50bp-90bp, more preferably, 60bp-80bp, eg, 70bp, 71bp, 72bp, 73bp, 74bp or 75bp.
  • the expression control element is placed upstream of the promoter; preferably, it is placed at 1bp-200bp upstream of the promoter, more preferably, 20bp-100bp, more preferably, 50bp-90bp, more preferably, 60bp-80bp, For example, 70bp, 71bp, 72bp, 73bp, 74bp or 75bp. .
  • the expression control element can also be set in the enhancer, intron, 5'-untranslated region (5'-UTR, also called leader sequence) or 3'-UTR, Transposons, terminator regions or within genes.
  • the same expression control element or a combination of different types of expression control elements can be used to control the expression level of the target gene; the same expression control element can be one copy of the expression control element, or multiple copies of the expression control element.
  • Expression regulatory elements can be used to control the expression level of the target gene; the same expression control element can be one copy of the expression control element, or multiple copies of the expression control element.
  • the expression control element comprises at least one expression control element of the invention, eg, 1-19, eg, 2, 3, 4, 5, 6, 7, 8 species, 9 species, 10 species, 11 species, 12 species, 13 species, 14 species, 15 species, 16 species, 17 species, 18 species or 19 species.
  • each of the expression regulatory elements comprises at least 1 copy of the expression regulatory element, e.g., 1-20 copies, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20.
  • multiple copies of the same or different expression regulatory elements can be linked in one or more of head-to-head, head-to-tail, tail-to-head, and tail-to-tail.
  • the present invention also provides a method for regulating the expression of a target gene in plant cells, the method comprising the step of regulating the expression of the target gene using the expression control element of the present invention.
  • the modulation is to increase the expression of the target gene.
  • the target gene may be an endogenous gene or an exogenous gene relative to the host cell.
  • the method comprises the step of introducing an expression regulatory element of the invention in the regulatory region of the gene of interest.
  • the present invention also provides a method for preparing a plant cell, plant tissue, plant part or plant with increased expression of a target gene, the method comprising utilizing the present invention in the plant cell, plant tissue, plant part or plant The expression regulatory element steps that increase the expression of the target gene.
  • the target gene may be an endogenous gene or an exogenous gene relative to a plant.
  • the method comprises the step of introducing an expression regulatory element of the invention in the regulatory region of the gene of interest.
  • the present invention also provides plant cells, plant tissues, plant parts or plants prepared by the aforementioned methods.
  • the present invention provides the use of the aforementioned expression regulatory elements, nucleic acid constructs or vectors in regulating gene expression.
  • the regulation of gene expression is to increase gene expression.
  • the present invention provides the use of the aforementioned expression control element, nucleic acid construct or vector in the preparation of cells with increased target gene expression;
  • the cells include prokaryotic cells and eukaryotic cells, preferably, plant cells.
  • the present invention provides the use of the aforementioned expression control elements, nucleic acid constructs or vectors in the preparation of plant cells, plant tissues, plant parts or plants with increased target gene expression.
  • the present invention provides the use of the aforementioned expression control element, nucleic acid construct or vector in the preparation of a reagent or kit for enhancing gene expression.
  • the present invention provides the use of the aforementioned expression control element, nucleic acid construct or vector in the preparation of a reagent or kit for increasing the expression level of a target gene in plant cells, plant tissues or plants.
  • nucleic acid refers to DNA, RNA, or hybrids thereof, which may be double-stranded or single-stranded.
  • compositions and methods of the present invention also comprise the nucleotide sequences and polypeptide sequences of the present invention (eg, SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.: 8.
  • encoding refers to the inherent property of a particular nucleotide sequence in a polynucleotide, such as a gene, cDNA or mRNA, as defined in a polynucleotide having a defined nucleotide sequence (ie, rRNA, tRNA and mRNA) or a defined amino acid sequence and its Templates for the synthesis of other polymers and macromolecules during biological processes that generate biological properties.
  • a gene encodes a protein if the transcription and translation of the mRNA corresponding to the gene produces the protein in a cell or other biological system.
  • expression regulatory element refers to a nucleotide sequence that up-regulates or down-regulates the expression of one or more genes.
  • regulatory element may function in “cis” or “trans”, and is usually “cis”, ie it activates the expression of a gene located on the same nucleic acid molecule (eg, chromosome) as the regulatory element.
  • Regulatory elements include promoters, enhancers, introns, 5'-untranslated regions (5'-UTRs, also known as leader sequences) or 3'-UTRs, transposons or terminators.
  • regulatory region generally includes regulatory elements such as promoters, enhancers, introns, 5'-untranslated regions (5'-UTRs) involved in regulating the transcription of nucleic acid molecules (eg, genes or target genes). , also known as the leader sequence) or 3'-UTR, transposons, regions where terminators are located, or other noncoding regions.
  • promoter has the meaning well known to those skilled in the art and refers to a non-coding nucleotide sequence located upstream of a gene that initiates expression of a downstream gene.
  • a constitutive promoter is a nucleotide sequence which, when operably linked to a polynucleotide encoding or defining the gene product, results in the gene product in a cell under most or all physiological conditions of the cell production.
  • An inducible promoter is a nucleotide sequence that, when operably linked to a polynucleotide encoding or defining a gene product, results in substantially only when an inducer corresponding to the promoter is present in a cell. The gene product is produced intracellularly.
  • a tissue-specific promoter is a nucleotide sequence that, when operably linked to a polynucleotide encoding or defining a gene product, results in substantially only when the cell is of the tissue type to which the promoter corresponds.
  • the gene product is produced in the cell.
  • operably linked is intended to mean that the nucleotide sequence of interest is linked to the one or more regulatory elements (e.g., , in an in vitro transcription/translation system or in a host cell when the vector is introduced into the host cell).
  • vector includes elements that allow the vector to integrate into the host cell genome or to replicate autonomously within the cell independent of the genome.
  • the vector may contain any elements that ensure self-replication. It usually carries genes that are not part of the central metabolism of the cell, and is usually in the form of double-stranded DNA.
  • the choice of vector will generally depend on the compatibility of the vector with the host cell into which the vector is to be introduced. If a vector is used, the choice of vector depends on methods well known to those skilled in the art for transforming host cells. For example, plasmid vectors can be used.
  • host cell is understood to mean any unicellular or multicellular organism, including, for example, bacteria such as E. coli, fungi such as yeast (eg Saccharomyces cerevisiae), molds (eg Aspergillus), plant cells and plants, and the like.
  • bacteria such as E. coli
  • fungi such as yeast (eg Saccharomyces cerevisiae)
  • molds eg Aspergillus
  • plant cells and plants and the like.
  • plant is to be understood as any differentiated multicellular organism capable of photosynthesis, including crop plants at any stage of maturity or development, in particular monocotyledonous or dicotyledonous plants, vegetable crops including artichokes, cabbage, Arugula, leeks, asparagus, lettuce (eg, head lettuce, leaf lettuce, romaine), bok choy, yellow taro, melons (eg, melon, watermelon, crenshaw ), white melon, romaine melon), canola crops (e.g., Brussels sprouts, cabbage, cauliflower, broccoli, kale, kale, Chinese cabbage, pak choi), spinach, carrots, napa, Okra, onions, celery, parsley, chickpeas, parsnips, chicory, peppers, potatoes, gourds (e.g., zucchini, cucumbers, zucchini, zucchini, squash), radishes, dried bulb onions, rutabagas, Purple eggplant (also called eggplant), salsify, endive, shallots
  • plant tissue or "plant part” includes plant cells, protoplasts, plant tissue cultures, plant callus, plant pieces as well as plant embryos, pollen, ovules, seeds, leaves, stems, flowers, shoots, seedlings, fruits , nucleus, ear, root, root tip, anther, etc.
  • plant cell is to be understood as any cell from or found in a plant, which is capable of forming, for example: undifferentiated tissue such as callus, differentiated tissue such as embryos, components of plants, plants or seeds.
  • CRISPR technology refers to clustered regularly interspaced short palindromic repeats (Clustered regularly interspaced short palindromic repeats), which are derived from the immune system of microorganisms.
  • gene editing tools include guideRNA, Cas proteins (such as Cas9, Cpf1, Cas12b, etc.).
  • Gene editing tools referred to in TALEN technology are restriction enzymes that can cut specific DNA sequences and include a TAL effector DNA binding domain and a DNA cleavage domain.
  • Gene editing tools referred to in ZFN technology are also restriction enzymes that can cut specific DNA sequences, including a zinc finger DNA binding domain and a DNA cleavage domain.
  • Vectors suitable for use in the present invention include commercially available plasmids such as but not limited to: pBR322 (ATCC37017), pKK223-3 (Pharmacia Fine Chemicals, Uppsala, Sweden), GEM1 (Promega Biotec, Madison, WI, USA) pQE70 , pQE60, pQE-9 (Qiagen), pD10, psiX174, pBluescript II KS, pNH8A, pNH16a, pNH18A, pNH46A (Stratagene), ptrc99a, pKK223-3, pKK233-3, pDR540, pRIT5 (Pharmacia), pKK232-8, pCM7, pSV2CAT, pOG44, pXT1, pSG (Stratagene), pSVK3, pBPV, pMSG, and pSVL (Pharmacia), among others.
  • nucleic acid sequences, nucleic acid constructs or expression vectors of the invention can be introduced into host cells by a variety of techniques, including transformation, transfection, transduction, viral infection, gene gun or Ti-plasmid mediated gene delivery, and calcium phosphate transfection transfection, DEAE-dextran-mediated transfection, lipofection or electroporation, etc.
  • the cells are cultured on a nutrient medium suitable for the production of the polypeptide using methods well known in the art. If the polypeptide is secreted into the nutrient medium, the polypeptide can be recovered directly from the medium. If the polypeptide is not secreted into the medium, it can be recovered from cell lysates.
  • the present invention screened out a group of expression control elements.
  • Connecting the expression control element of the present invention to the target gene can significantly increase the expression level of the target gene.
  • Figure 1 The composition of the screening vector, the enhancer is the 64 expression control element sequences to be screened, Mini35S is the modified promoter with weak transcriptional activation ability, and GUS is the ⁇ -glucuronidase gene ( ⁇ -glucuronidase) .
  • the positive control is the Gus plasmid started with mini35S
  • the negative control is the Gus plasmid started with the modified mini35S.
  • Figure 2A is an assay for the activity of A1-A8 expression regulatory elements.
  • Figure 2B is an assay for the activity of B1-B8 expression regulatory elements.
  • Figure 2C is the detection of the activity of C1-C8, D1-D8 expression regulatory elements.
  • Figure 2D is an assay for the activity of E1-E8 expression regulatory elements.
  • Figure 2E is an assay for the activity of F1-F8 expression regulatory elements.
  • Figure 2F is the detection of G1-G8, H1-H8 expression regulatory element activity.
  • FIG. 3 The composition of the relative fluorescence measurement vector, the enhancer is the sequence of the five expression control elements to be determined, Mini35S is a modified promoter with weak transcriptional activation ability, mCherry is a red fluorescent group, and 2 ⁇ 35s is normal The promoter of transcriptional activation ability, GPF is green fluorescent protein, Nos and E9 are common terminators.
  • FIG. 4 Gus staining of transformed seedlings stably containing plasmids with different expression regulatory elements.
  • WT did not do any treatment of Arabidopsis thaliana seedlings
  • mini35S is a transformed seedling with the transformed mini35S promoter as the promoter, and it is a negative control
  • 35S is a transformed seedling with the 35S promoter as a promoter, which is a positive control (Fig. "1301")
  • the other 3 transformed seedlings were respectively added with F4 expression control elements, F5 expression control elements and F8 expression control elements in the modified mini35 regulatory region to verify the F4 expression control elements, F5 expression control elements and F8 expression control elements function of the element.
  • the pCAMBIA1301-mini35S(82bp)-GUS screening plasmid was constructed, in which the mini35S(82bp) promoter has weak transcriptional activation ability. After the regulatory region of mini35s (82bp) is connected to the screened expression regulatory element, if the expression level of GUS is significantly increased, it indicates that the expression regulatory element has the ability to improve gene expression.
  • the wild-type enhancer sequence was expanded to 64 according to the sequence of its non-conserved site (the group number is AH, a total of 8 groups, each group is numbered 1-8 in sequence, the names and sequences are shown in Table 1).
  • the pCAMBIA1301-mini35S(82bp)-GUS screening plasmids connected to 64 expression control element sequences constitute 64 different plasmids to be screened.
  • the sequence after connecting with mini35s (82bp) is (A1 is underlined, mini35s (82bp) is marked in bold italics, and the interval between TATA box and A1 is 75bp), and other expression control elements are added in the same way as A1.
  • Protoplast transformation was performed on the plasmid containing the sequence to be screened, followed by GUS staining:
  • the positive control is the Gus plasmid started with mini35S
  • the negative control is the Gus plasmid started with the modified mini35S (82bp).
  • the mini35S promoter can normally start the expression of the Gus gene, but it is basically lost after the transformation. promoter activity. If a more obvious blue color is observed after adding the expression control element before the modified mini35S (82bp), it indicates that the expression control element does have enhanced activity.
  • A2, A5, A7, and A8 could significantly increase the expression of GUS.
  • B2 and B4 could significantly increase the expression of GUS.
  • C1, C4, C7, C8, D4 could significantly increase the expression of GUS.
  • E1 could significantly increase the expression of GUS.
  • F3, F4, F5, and F8 could significantly increase the expression of GUS.
  • G1, G3, and G7 could significantly increase the expression of GUS.
  • the expression control elements D4, E1, F4, F5 and F8 in the above-mentioned embodiment are selected and connected with the mCherry fluorophore started with mini35 (82bp) respectively, and the GFP gene started with the 35S promoter is also included on the carrier, forming a relative Fluorescence measurement carrier.
  • the expression control element to be verified is connected to the vector in the manner shown in Figure 3, and the connection between the enhancer and mini35s (82bp) is the same as that in Example 1, and five constructed relative fluorescence measurement vectors and a negative control ( Protoplast transformation was performed 24 hours after transformation, and the relative fluorescence intensity was measured with the normalized GFP fluorescence intensity as a reference.
  • Mini35S is the modified promoter Mini35S (82bp) with weak transcriptional activation ability
  • mCherry is the red fluorescent group
  • 2X 35s is the promoter with normal transcriptional activation ability
  • GPF is the green fluorescent protein
  • Nos and E9 are common terminators.
  • FmCherry is the average of all red fluorescent protein (mCherry) luminescence intensities in three different fields of view; FGFP is the average of all green fluorescent protein (GFP) luminescence intensities in three different fields of view.
  • mCherry red fluorescent protein
  • GFP green fluorescent protein
  • the vectors containing D4, E1, F4, F5 and F8 expression control elements have significantly higher mCherry fluorescence and higher relative fluorescence intensity than those without expression control elements, which proves that 5 Each expression regulatory element does have a strong effect on improving the expression of the target gene.
  • the vector double fluorescence detection vector containing 3 copies of F4 and 3 copies of F5 expression control elements was constructed respectively. Each expression regulatory element was placed end to end and inserted 75 bp upstream of the mini35S (82 bp) promoter. After inserting 3 copies of F4, the sequences of the mini35S (82bp) promoter and enhancer are: (The underlined is 3 copies of F4, the bold italic is marked with mini35s (82bp), the TATA box and the most downstream F4 are separated by 75bp), the 3 copies of F5 expression regulatory elements are added in the same way as F4.
  • the PUN1 core promoter in 319bp pepper was amplified, and F4, F5 and F8 were respectively fused to the TATA box upstream of the promoter of the capsaicin synthase gene PUN1 by BstEII digestion.
  • the connected promoter and enhancer sequences were (The underlined is 3 copies of F4, and the bold italics is the PUN1 core promoter); other expression control elements are added in the same manner as above.
  • the modified promoter was fused with mCherry to form pCAMBIA1301-pPUN1(enhancer)::mCherry-Tnos-35S::GFP-TE9 dual fluorescent vector.
  • the vector was transformed into capsicum placenta protoplasts by PEG-mediated method, and the relative fluorescence intensity was measured and calculated.
  • the expression control element of the present invention is inserted into the regulatory region of the target gene by means of gene editing, and the expression level of the gene is detected by RT-PCR and western methods, and an increase in the expression level can be obviously detected.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides an expression regulatory element and a use thereof, and relates in particular to an expression regulatory element and a use thereof in regulating the expression of one or more genes in a cell. Further disclosed is a use of an expression regulatory element in plant breeding. Further disclosed is a method for improving the expression of a target gene by using an expression regulatory element of the invention. The method comprises: operably linking an expression regulatory element of the present invention to a target gene, so as to improve the expression of the target gene.

Description

一种表达调控元件及其应用An expression control element and its application 技术领域technical field
本发明属于生物技术领域,具体涉及一种表达调控元件及其在调节基因表达中的应用。The invention belongs to the field of biotechnology, and in particular relates to an expression control element and its application in regulating gene expression.
背景技术Background technique
在作物遗传改良过程中,如何提高部分基因表达的表达量是一直以来需要解决的重要问题之一。顺式作用元件是指与结构基因串联的特定DNA序列,是转录因子的结合位点,通过与转录因子结合而调控基因转录。结合转录因子之后能够增强转录作用的顺式元件被称为增强子。通过在目的基因的调控区添加增强子,或许能够实现在不显著改变基因表达模式的前提下有效提高目的基因表达。In the process of crop genetic improvement, how to improve the expression level of some genes is one of the important issues that needs to be solved. A cis-acting element refers to a specific DNA sequence in series with a structural gene, which is the binding site of a transcription factor and regulates gene transcription by binding to a transcription factor. A cis-element that enhances transcription upon binding to a transcription factor is called an enhancer. By adding an enhancer to the regulatory region of the target gene, it may be possible to effectively increase the expression of the target gene without significantly changing the gene expression pattern.
OCS基因在农杆菌中编码章鱼碱合成酶,其启动子部分具有与真核生物启动子相似的TATA box与CAAT box,能在植物细胞中普遍表达,具有植物启动子的特性。OCS启动子部分存在一个重要的16bp回文序列(ACGTAAGCGCTTACGT),具有显著的增强子活性。分析其他在植物中广泛使用的强启动子序列后发现,还存在其他与OCS具有一定同源性的表达调控元件序列,根据这些序列的特征对OCS元件进行改造,以期筛选能够提高基因表达水平的新的表达调控元件。The OCS gene encodes octopine synthase in Agrobacterium, and its promoter part has TATA box and CAAT box similar to eukaryotic promoters, which can be ubiquitously expressed in plant cells and has the characteristics of plant promoters. There is an important 16bp palindromic sequence (ACGTAAGCGCTTACGT) in the OCS promoter part, which has significant enhancer activity. After analyzing other strong promoter sequences widely used in plants, it was found that there are other expression control element sequences with certain homology to OCS. According to the characteristics of these sequences, the OCS elements were modified, in order to screen for genes that can improve the level of gene expression. Novel expression regulatory elements.
发明内容SUMMARY OF THE INVENTION
本发明目的是提供一种表达调控元件及其应用。本发明通过改变野生型增强子序列,设计64条待筛选的表达调控元件,连接到表达载体进行筛选,得到了19种功能增强的表达调控元件,这19种表达调控元件在提高基因表达水平方面有显著效果。The purpose of the present invention is to provide an expression control element and its application. By changing the wild-type enhancer sequence, the present invention designs 64 expression control elements to be screened, connects to the expression vector for screening, and obtains 19 kinds of expression control elements with enhanced functions. These 19 kinds of expression control elements can improve the level of gene expression. have a significant effect.
表达调控元件expression regulatory element
一方面,本发明提供了一种表达调控元件,所述表达调控元件包含SEQ ID NO.:1-64任一所示的核苷酸序列或者与其互补的核苷酸序列。In one aspect, the present invention provides an expression control element comprising the nucleotide sequence shown in any of SEQ ID NO.: 1-64 or a nucleotide sequence complementary thereto.
在一个实施方式中,所述表达调控元件包含SEQ ID NO.:2、SEQ ID NO.:5、SEQ ID NO.:7、SEQ ID NO.:8、SEQ ID NO.:10、SEQ ID NO.:12、SEQ ID NO.:17、SEQ ID NO.:20、SEQ ID NO.:23、SEQ ID NO.:24、SEQ ID NO.:28、SEQ ID NO.:33、SEQ ID NO.:43、SEQ ID NO.:44、SEQ ID NO.:45、SEQ ID NO.:48、SEQ ID NO.:49、SEQ ID NO.:51或SEQ ID NO.:55中任一所示的多核苷酸序列;优选,SEQ ID NO.:28、SEQ ID NO.:33、SEQ ID NO.:44、SEQ ID NO.:45或SEQ ID NO.:48中任一所示的多核苷酸序列。In one embodiment, the expression control element comprises SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.:8, SEQ ID NO.:10, SEQ ID NO. .:12, SEQ ID NO.:17, SEQ ID NO.:20, SEQ ID NO.:23, SEQ ID NO.:24, SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO. :43, SEQ ID NO.:44, SEQ ID NO.:45, SEQ ID NO.:48, SEQ ID NO.:49, SEQ ID NO.:51 or SEQ ID NO.:55 Polynucleotide sequence; preferably, the polynucleotide shown in any of SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO.:44, SEQ ID NO.:45 or SEQ ID NO.:48 sequence.
在一个实施方式中,所述表达调控元件为SEQ ID NO.:2、SEQ ID NO.:5、SEQ ID NO.:7、SEQ ID NO.:8、SEQ ID NO.:10、SEQ ID NO.:12、SEQ ID NO.:17、 SEQ ID NO.:20、SEQ ID NO.:23、SEQ ID NO.:24、SEQ ID NO.:28、SEQ ID NO.:33、SEQ ID NO.:43、SEQ ID NO.:44、SEQ ID NO.:45、SEQ ID NO.:48、SEQ ID NO.:49、SEQ ID NO.:51或SEQ ID NO.:55中任一所示的多核苷酸序列;优选,SEQ ID NO.:28、SEQ ID NO.:33、SEQ ID NO.:44、SEQ ID NO.:45或SEQ ID NO.:48中任一所示的多核苷酸序列。In one embodiment, the expression control element is SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.:8, SEQ ID NO.:10, SEQ ID NO. .:12, SEQ ID NO.:17, SEQ ID NO.:20, SEQ ID NO.:23, SEQ ID NO.:24, SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO. :43, SEQ ID NO.:44, SEQ ID NO.:45, SEQ ID NO.:48, SEQ ID NO.:49, SEQ ID NO.:51 or SEQ ID NO.:55 Polynucleotide sequence; preferably, the polynucleotide shown in any of SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO.:44, SEQ ID NO.:45 or SEQ ID NO.:48 sequence.
在一个实施方式中,所述表达调控元件与SEQ ID NO.:2、SEQ ID NO.:5、SEQ ID NO.:7、SEQ ID NO.:8、SEQ ID NO.:10、SEQ ID NO.:12、SEQ ID NO.:17、SEQ ID NO.:20、SEQ ID NO.:23、SEQ ID NO.:24、SEQ ID NO.:28、SEQ ID NO.:33、SEQ ID NO.:43、SEQ ID NO.:44、SEQ ID NO.:45、SEQ ID NO.:48、SEQ ID NO.:49、SEQ ID NO.:51或SEQ ID NO.:55中任一所示序列的同源性≥80%(较佳地≥90%,更佳地≥95%,≥96%,≥97%,≥98%,最佳地≥99%)。In one embodiment, the expression regulatory element is associated with SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.:8, SEQ ID NO.:10, SEQ ID NO. .:12, SEQ ID NO.:17, SEQ ID NO.:20, SEQ ID NO.:23, SEQ ID NO.:24, SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO. :43, SEQ ID NO.:44, SEQ ID NO.:45, SEQ ID NO.:48, SEQ ID NO.:49, SEQ ID NO.:51 or SEQ ID NO.:55 The homology of ≥80% (preferably ≥90%, more preferably ≥95%, ≥96%, ≥97%, ≥98%, optimally ≥99%).
在一个实施方式中,所述表达调控元件为与SEQ ID NO.:2、SEQ ID NO.:5、SEQ ID NO.:7、SEQ ID NO.:8、SEQ ID NO.:10、SEQ ID NO.:12、SEQ ID NO.:17、SEQ ID NO.:20、SEQ ID NO.:23、SEQ ID NO.:24、SEQ ID NO.:28、SEQ ID NO.:33、SEQ ID NO.:43、SEQ ID NO.:44、SEQ ID NO.:45、SEQ ID NO.:48、SEQ ID NO.:49、SEQ ID NO.:51或SEQ ID NO.:55中所示任一序列互补的多核苷酸。In one embodiment, the expression control element is the same as SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.:8, SEQ ID NO.:10, SEQ ID NO.:10, SEQ ID NO.:10, SEQ ID NO. NO.:12, SEQ ID NO.:17, SEQ ID NO.:20, SEQ ID NO.:23, SEQ ID NO.:24, SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO .:43, SEQ ID NO.:44, SEQ ID NO.:45, SEQ ID NO.:48, SEQ ID NO.:49, SEQ ID NO.:51 or SEQ ID NO.:55 sequence-complementary polynucleotides.
在一个实施方式中,所述的多核苷酸优选是单链的或双链的。In one embodiment, the polynucleotide is preferably single-stranded or double-stranded.
核酸构建物nucleic acid construct
另一方面,本发明提供了一种核酸构建物,含有前述的表达调控元件以及与之可操作连接的调节元件或目标基因。In another aspect, the present invention provides a nucleic acid construct comprising the aforementioned expression regulatory element and a regulatory element or target gene operably linked thereto.
在一个实施方式中,所述的调节元件选自下组中的一种或多种:启动子、增强子、内含子、5’-非翻译区(5’-UTR,还被称为前导序列)、3’-UTR、转座子、终止子、多腺苷酸序列、标记基因或其组合。In one embodiment, the regulatory element is selected from one or more of the group consisting of promoter, enhancer, intron, 5'-untranslated region (5'-UTR, also known as leader sequence), 3'-UTR, transposon, terminator, polyadenylation sequence, marker gene, or a combination thereof.
在一个实施例中,所述目标基因包括除草剂耐受性、昆虫抗性、抗病性、非生物胁迫耐受性、产率稳定性、产率增加、碳水化合物代谢、脂肪酸代谢、氨基酸代谢、植物发育、植物生长调节、抗旱性、抗寒性、抗热性、养分利用效率、氮利用效率和抗盐性的基因、microRNA(小RNA)及小RNA前体。In one embodiment, the gene of interest comprises herbicide tolerance, insect resistance, disease resistance, abiotic stress tolerance, yield stability, increased yield, carbohydrate metabolism, fatty acid metabolism, amino acid metabolism , Plant development, plant growth regulation, drought resistance, cold resistance, heat resistance, nutrient use efficiency, nitrogen use efficiency and salt resistance genes, microRNAs (small RNAs) and small RNA precursors.
载体carrier
本发明还提供了一种载体,所述载体包含有上述表达调控元件和/或核酸构建物,优选的,所述载体还包括与上述表达调控元件和/或核酸构建物可操作连接的调节元件或目标基因。The present invention also provides a vector, which contains the above-mentioned expression control element and/or nucleic acid construct, preferably, the vector further includes a regulatory element operably linked to the above-mentioned expression control element and/or nucleic acid construct or target gene.
在一个实施例中,所述目标基因选自植物基因或非植物基因,所述非植物基因包括来源于真核生物或原核生物的基因。In one embodiment, the target gene is selected from plant genes or non-plant genes, and the non-plant genes include genes derived from eukaryotes or prokaryotes.
在一个实施例中,所述目标基因包括除草剂耐受性、昆虫抗性、抗病性、 非生物胁迫耐受性、产率稳定性、产率增加、碳水化合物代谢、脂肪酸代谢、氨基酸代谢、植物发育、植物生长调节、抗旱性、抗寒性、抗热性、养分利用效率、氮利用效率和抗盐性的基因、microRNA(小RNA)及小RNA前体。In one embodiment, the gene of interest comprises herbicide tolerance, insect resistance, disease resistance, abiotic stress tolerance, yield stability, increased yield, carbohydrate metabolism, fatty acid metabolism, amino acid metabolism , Plant development, plant growth regulation, drought resistance, cold resistance, heat resistance, nutrient use efficiency, nitrogen use efficiency and salt resistance genes, microRNA (small RNA) and small RNA precursors.
在一个实施方式中,所述的载体包括克隆载体、表达载体、穿梭载体、整合载体。In one embodiment, the vectors include cloning vectors, expression vectors, shuttle vectors, and integration vectors.
在一个实施方式中,所述表达载体中还至少含有一个复制起点,以实现自我复制。In one embodiment, the expression vector further contains at least one origin of replication to achieve self-replication.
在一个实施方式中,所述载体可以是当引入宿主细胞时被整合入基因组中并与其所整合入的染色体一起复制的载体。In one embodiment, the vector may be one that, when introduced into a host cell, is integrated into the genome and replicated together with the chromosome into which it is integrated.
载体可以是质粒、病毒、粘粒、噬菌体等类型,它们是本领域技术人员所熟知的。Vectors can be of the type plasmid, virus, cosmid, phage, etc., which are well known to those skilled in the art.
优选地,本发明中的载体是质粒。Preferably, the vector in the present invention is a plasmid.
宿主细胞host cell
另一方面,本发明提供了一种宿主细胞,所述的宿主细胞含有前述表达调控元件、核酸构建物和载体中的一种或多种。In another aspect, the present invention provides a host cell containing one or more of the aforementioned expression control elements, nucleic acid constructs and vectors.
在一个实施方式中,所述宿主细胞的基因组中整合有前述的表达调控元件。In one embodiment, the aforementioned expression control element is integrated into the genome of the host cell.
在一个实施方式中,所述的宿主细胞为原核细胞,如大肠杆菌、农杆菌。In one embodiment, the host cell is a prokaryotic cell, such as Escherichia coli, Agrobacterium.
在一个实施方式中,所述的宿主细胞为真核细胞,包括动物细胞、植物细胞、真菌等;优选的,所述真核细胞为植物细胞,优选的,所述植物包括被子植物和裸子植物。In one embodiment, the host cells are eukaryotic cells, including animal cells, plant cells, fungi, etc.; preferably, the eukaryotic cells are plant cells, and preferably, the plants include angiosperms and gymnosperms .
在一个实施方式中,所述植物包括单子叶植物和双子叶植物。In one embodiment, the plants include monocotyledonous and dicotyledonous plants.
在一个实施方式中,所述植物包括草本植物和木本植物。In one embodiment, the plants include herbaceous and woody plants.
在一个实施方式中,所述植物包括拟南芥、烟草、水稻、玉米、高粱、大麦、小麦、小米、大豆、番茄、马铃薯、藜麦、生菜、油菜、白菜、草莓。In one embodiment, the plant comprises Arabidopsis, tobacco, rice, corn, sorghum, barley, wheat, millet, soybean, tomato, potato, quinoa, lettuce, canola, cabbage, strawberry.
植物plant
本发明还提供了一种载体稳定转化的植物,所述载体包含有本发明表达调控元件;优选的,所述载体包括本发明表达调控元件及目标基因。The present invention also provides a plant stably transformed by a vector, wherein the vector contains the expression control element of the present invention; preferably, the vector includes the expression control element of the present invention and a target gene.
本发明还提供了一种目标基因表达量提高的植物,所述目标基因的调节区中包含本发明表达调控元件。The present invention also provides a plant with increased expression of a target gene, wherein the regulatory region of the target gene comprises the expression control element of the present invention.
所述表达调控元件可以通过改变目标基因的调节区中的一个或多个核苷酸得到的,也可以是通过基因编辑的方式引入得到,或者是通过在目标基因的调节区中插入本发明的表达调控元件得到。The expression control element can be obtained by changing one or more nucleotides in the regulatory region of the target gene, or can be introduced by gene editing, or inserted into the regulatory region of the target gene. Expression regulatory elements are obtained.
方法method
本发明还提供了一种调控目标基因表达的方法,所述方法包括利用本发明 的表达调控元件调控目标基因表达的步骤。The present invention also provides a method for regulating the expression of a target gene, the method comprising the step of regulating the expression of the target gene using the expression control element of the present invention.
在优选的实施方式中,所述调控目标基因表达为提高目标基因表达。In a preferred embodiment, the regulation of target gene expression is to increase target gene expression.
在一个实施例中,所述目标基因相对于宿主细胞来说,可以是内源基因,也可以是外源基因。In one embodiment, the target gene may be an endogenous gene or an exogenous gene relative to the host cell.
在一个实施例中,所述目标基因包括除草剂耐受性、昆虫抗性、抗病性、非生物胁迫耐受性、产率稳定性、产率增加、碳水化合物代谢、脂肪酸代谢、氨基酸代谢、植物发育、植物生长调节、抗旱性、抗寒性、抗热性、养分利用效率、氮利用效率和抗盐性的基因、microRNA(小RNA)及小RNA前体。In one embodiment, the gene of interest comprises herbicide tolerance, insect resistance, disease resistance, abiotic stress tolerance, yield stability, increased yield, carbohydrate metabolism, fatty acid metabolism, amino acid metabolism , Plant development, plant growth regulation, drought resistance, cold resistance, heat resistance, nutrient use efficiency, nitrogen use efficiency and salt resistance genes, microRNA (small RNA) and small RNA precursors.
在一个实施方式中,所述调控目标基因标的方法包括在目标基因的调节区中引入本发明的表达调控元件的步骤。In one embodiment, the method for regulating a target gene target comprises the step of introducing the expression control element of the present invention into the regulatory region of the target gene.
术语“调节区”通常是指参与调控核酸分子(例如基因或靶基因)的转录的调节成分(regulatory elements),如启动子、增强子、内含子、5’-非翻译区(5’-UTR,还被称为前导序列)或3’-UTR、转座子、终止子所在的区域或其他非编码区。The term "regulatory region" generally refers to regulatory elements, such as promoters, enhancers, introns, 5'-untranslated regions (5'- UTR, also known as leader sequence) or 3'-UTR, transposon, region where terminator is located, or other non-coding region.
在优选的实施方式中,所述调节区为启动子所在的区域或启动子上游。In a preferred embodiment, the regulatory region is the region where the promoter is located or upstream of the promoter.
在目标基因的调节区中引入本发明的表达调控元件,可以通过以下方式实现:通过对目标基因的调节区中的1个或多个核酸进行编辑从而使得调节区中包括有本发明的表达调控元件,或者,在目标基因的调节区中插入本发明的表达调控元件从而使得调节区中包括有本发明的表达调控元件。所述编辑包括对核酸的改变、缺失、插入等方式。The introduction of the expression regulatory element of the present invention into the regulatory region of the target gene can be achieved by the following manner: by editing one or more nucleic acids in the regulatory region of the target gene, the regulatory region includes the expression regulatory element of the present invention Alternatively, the expression regulatory element of the present invention is inserted into the regulatory region of the target gene so that the regulatory region includes the expression regulatory element of the present invention. The editing includes changes, deletions, insertions and the like to nucleic acids.
在一个实施方式中,在目标基因的调节区中引入本发明的表达调控元件,可以通过同源重组、基因编辑(例如CRISPR技术、TALEN技术、ZFN技术)来实现。In one embodiment, the expression regulatory element of the present invention is introduced into the regulatory region of the target gene, which can be achieved by homologous recombination, gene editing (eg, CRISPR technology, TALEN technology, ZFN technology).
在一个实施方式中,所述方法包括将至少1个拷贝的本发明的表达调控元件插入到目标基因的调节区中。In one embodiment, the method comprises inserting at least 1 copy of the expression regulatory element of the invention into the regulatory region of the gene of interest.
在一个实施方式中,所述表达调控元件设置在目标基因的转录起始位点的上游或下游的0-5000bp之内,优选的0-2000bp之内,优选的0-550bp之内,优选的0-200bp之内。优选的,所述表达调控元件在转录起始位点的上游,或者下游。In one embodiment, the expression control element is set within 0-5000bp upstream or downstream of the transcription initiation site of the target gene, preferably within 0-2000bp, preferably within 0-550bp, preferably within 0-550bp Within 0-200bp. Preferably, the expression control element is upstream or downstream of the transcription initiation site.
在一个实施方式中,所述表达调控元件设置于启动子区域;优选的,设置于启动子区域TATA box的上游1bp-200bp,更优选,20bp-100bp,更优选,50bp-90bp,更优选,60bp-80bp,例如,70bp、71bp、72bp、73bp、74bp或75bp。In one embodiment, the expression control element is set in the promoter region; preferably, it is set in the upstream 1bp-200bp of the TATA box in the promoter region, more preferably, 20bp-100bp, more preferably, 50bp-90bp, more preferably, 60bp-80bp, eg, 70bp, 71bp, 72bp, 73bp, 74bp or 75bp.
在一个实施方式中,所述表达调控元件置于启动子上游;优选的,设置于 启动子上游1bp-200bp,更优选,20bp-100bp,更优选,50bp-90bp,更优选,60bp-80bp,例如,70bp、71bp、72bp、73bp、74bp或75bp。。In one embodiment, the expression control element is placed upstream of the promoter; preferably, it is placed at 1bp-200bp upstream of the promoter, more preferably, 20bp-100bp, more preferably, 50bp-90bp, more preferably, 60bp-80bp, For example, 70bp, 71bp, 72bp, 73bp, 74bp or 75bp. .
在一个实施方式中,所述表达调控元件还可以设置于目标基因的增强子、内含子、5’-非翻译区(5’-UTR,还被称为前导序列)或3’-UTR、转座子、终止子区域或基因内部。In one embodiment, the expression control element can also be set in the enhancer, intron, 5'-untranslated region (5'-UTR, also called leader sequence) or 3'-UTR, Transposons, terminator regions or within genes.
本发明中,可以采用同一种表达调控元件或不同种类的表达调控元件组合使用以调控目标基因的表达量;同一种表达调控元件可以为1个拷贝的表达调控元件,也可以是多个拷贝的表达调控元件。In the present invention, the same expression control element or a combination of different types of expression control elements can be used to control the expression level of the target gene; the same expression control element can be one copy of the expression control element, or multiple copies of the expression control element. Expression regulatory elements.
在一个实施方式中,所述表达调控元件包括至少一种本发明的表达调控元件,例如,1-19种,例如,2种、3种、4种、5种、6种、7种、8种、9种、10种、11种、12种、13种、14种、15种、16种、17种、18种或19种。In one embodiment, the expression control element comprises at least one expression control element of the invention, eg, 1-19, eg, 2, 3, 4, 5, 6, 7, 8 species, 9 species, 10 species, 11 species, 12 species, 13 species, 14 species, 15 species, 16 species, 17 species, 18 species or 19 species.
在其他的实施方式中,所述每种表达调控元件包括至少1个拷贝的表达调控元件,例如,1-20个拷贝,2个,3个,4个,5个,6个,7个,8个,9个,10个,15个,20个。In other embodiments, each of the expression regulatory elements comprises at least 1 copy of the expression regulatory element, e.g., 1-20 copies, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20.
在一个实施方式中,多拷贝的相同或不同的表达调控元件之间可以有间隔子序列,所述间隔子序列可以是1-200个核苷酸,优选1-50个核苷酸。In one embodiment, there may be spacer sequences between multiple copies of the same or different expression control elements, and the spacer sequences may be 1-200 nucleotides, preferably 1-50 nucleotides.
在一个实施方式中,多拷贝的相同或不同的表达调控元件可以以头对头、头对尾、尾对头和尾对尾中的一个或多个方式连接。In one embodiment, multiple copies of the same or different expression regulatory elements can be linked in one or more of head-to-head, head-to-tail, tail-to-head, and tail-to-tail.
另一方面,本发明还提供了一种调控目标基因在植物细胞中的表达的方法,所述方法包括利用本发明的表达调控元件调控目标基因表达的步骤。In another aspect, the present invention also provides a method for regulating the expression of a target gene in plant cells, the method comprising the step of regulating the expression of the target gene using the expression control element of the present invention.
在优选的实施方式中,所述调控为提高目标基因的表达。In a preferred embodiment, the modulation is to increase the expression of the target gene.
在一个实施例中,所述目标基因相对于宿主细胞来说,可以是内源基因,也可以是外源基因。In one embodiment, the target gene may be an endogenous gene or an exogenous gene relative to the host cell.
在一个实施方式中,所述方法包括在目标基因的调节区中引入本发明的表达调控元件的步骤。In one embodiment, the method comprises the step of introducing an expression regulatory element of the invention in the regulatory region of the gene of interest.
另一方面,本发明还提供了一种制备目标基因表达量提高的植物细胞、植物组织、植物部分或植物的方法,所述方法包括在植物细胞、植物组织、植物部分或植物中利用本发明的表达调控元件提高目标基因表达的步骤。In another aspect, the present invention also provides a method for preparing a plant cell, plant tissue, plant part or plant with increased expression of a target gene, the method comprising utilizing the present invention in the plant cell, plant tissue, plant part or plant The expression regulatory element steps that increase the expression of the target gene.
在一个实施例中,所述目标基因相对于植物来说,可以是内源基因,也可以是外源基因。在一个实施方式中,所述方法包括在目标基因的调节区中引入本发明的表达调控元件的步骤。In one embodiment, the target gene may be an endogenous gene or an exogenous gene relative to a plant. In one embodiment, the method comprises the step of introducing an expression regulatory element of the invention in the regulatory region of the gene of interest.
另一方面,本发明还提供了由前述方法制备得到的植物细胞、植物组织、植物部分或植物。In another aspect, the present invention also provides plant cells, plant tissues, plant parts or plants prepared by the aforementioned methods.
用途use
另一方面,本发明提供了前述表达调控元件、核酸构建物或载体在调控基因表达中的用途。优选的,所述调控基因表达为提高基因表达。In another aspect, the present invention provides the use of the aforementioned expression regulatory elements, nucleic acid constructs or vectors in regulating gene expression. Preferably, the regulation of gene expression is to increase gene expression.
另一方面,本发明提供了前述表达调控元件、核酸构建物或载体在制备目标基因表达量提高的细胞中的用途;所述细胞包括原核细胞和真核细胞,优选,植物细胞。In another aspect, the present invention provides the use of the aforementioned expression control element, nucleic acid construct or vector in the preparation of cells with increased target gene expression; the cells include prokaryotic cells and eukaryotic cells, preferably, plant cells.
另一方面,本发明提供了前述表达调控元件、核酸构建物或载体在制备目标基因表达量提高的植物细胞、植物组织、植物部分或植物中的用途。In another aspect, the present invention provides the use of the aforementioned expression control elements, nucleic acid constructs or vectors in the preparation of plant cells, plant tissues, plant parts or plants with increased target gene expression.
另一方面,本发明提供了前述表达调控元件、核酸构建物或载体在制备提高基因表达的试剂或试剂盒中的用途。In another aspect, the present invention provides the use of the aforementioned expression control element, nucleic acid construct or vector in the preparation of a reagent or kit for enhancing gene expression.
另一方面,本发明提供了前述表达调控元件、核酸构建物或载体在制备用于在植物细胞、植物组织或植物中提高目标基因表达量的试剂或试剂盒中的用途。In another aspect, the present invention provides the use of the aforementioned expression control element, nucleic acid construct or vector in the preparation of a reagent or kit for increasing the expression level of a target gene in plant cells, plant tissues or plants.
一般定义General Definition
除非另有定义,否则本文所用的技术和科学术语具有与所属领域的普通技术人员之一通常理解的相同的含义。Unless otherwise defined, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art.
术语“多核苷酸”、“核苷酸序列”、“核酸序列”、“核酸分子”和“核酸”可以互换使用,包括DNA、RNA或者其杂交体,可以是双链或单链的。The terms "polynucleotide," "nucleotide sequence," "nucleic acid sequence," "nucleic acid molecule," and "nucleic acid" are used interchangeably and include DNA, RNA, or hybrids thereof, which may be double-stranded or single-stranded.
术语“同源性”或“同一性”用于指两个多肽之间或两个核酸之间序列的匹配情况。因此,本发明的组合物和方法还包含本发明的核苷酸序列和多肽序列(例如,SEQ ID NO.:2、SEQ ID NO.:5、SEQ ID NO.:7、SEQ ID NO.:8、SEQ ID NO.:10、SEQ ID NO.:12、SEQ ID NO.:17、SEQ ID NO.:20、SEQ ID NO.:23、SEQ ID NO.:24、SEQ ID NO.:28、SEQ ID NO.:33、SEQ ID NO.:43、SEQ ID NO.:44、SEQ ID NO.:45、SEQ ID NO.:48、SEQ ID NO.:49、SEQ ID NO.:51或SEQ ID NO.:55中)的同源物。可以通过包括但不限于以下的已知方法计算“同源性”:Computational Molecular Biology[计算分子生物学](Lesk,A.M.编辑)Oxford University Press[牛津大学出版社],纽约(1988);Biocomputing:Informatics and Genome Projects[生物运算:信息学和基因组项目](Smith,D.W.编辑)Academic Press[学术出版社],纽约(1993);Computer Analysis of Sequence Data,Part I[序列数据的计算机分析,第I部分](Griffin,A.M.和Griffin,H.G.编辑)Humana Press[胡马纳出版社],新泽西州(1994);Sequence Analysis in Molecular Biology[分子生物学中的序列分析](von Heinje,G.编辑)Academic Press[学术出版社](1987);以及Sequence Analysis Primer[序列分析引物](Gribskov,M.和Devereux,J.编辑)Stockton Press[斯托克顿出版社],纽约(1991)。The terms "homology" or "identity" are used to refer to the matching of sequences between two polypeptides or between two nucleic acids. Accordingly, the compositions and methods of the present invention also comprise the nucleotide sequences and polypeptide sequences of the present invention (eg, SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.: 8. SEQ ID NO.:10, SEQ ID NO.:12, SEQ ID NO.:17, SEQ ID NO.:20, SEQ ID NO.:23, SEQ ID NO.:24, SEQ ID NO.:28 , SEQ ID NO.:33, SEQ ID NO.:43, SEQ ID NO.:44, SEQ ID NO.:45, SEQ ID NO.:48, SEQ ID NO.:49, SEQ ID NO.:51 or Homologue of SEQ ID NO.:55). "Homology" can be calculated by known methods including, but not limited to, Computational Molecular Biology (Lesk, A.M. ed.) Oxford University Press, New York (1988); Biocomputing: Informatics and Genome Projects [Biocomputing: Informatics and Genome Projects] (Smith, D.W. ed.) Academic Press [Academic Press], New York (1993); Computer Analysis of Sequence Data, Part I [Computer Analysis of Sequence Data, Part I Section] (edited by Griffin, A.M. and Griffin, H.G.) Humana Press [Humana Press], New Jersey (1994); Sequence Analysis in Molecular Biology] (edited by von Heinje, G.) Academic Press [Academic Press] (1987); and Sequence Analysis Primer (edited by Gribskov, M. and Devereux, J.) Stockton Press [Stockton Press], New York (1991).
术语“编码”是指多核苷酸中特定核苷酸序列的固有特性,例如基因,cDNA或mRNA,作为在具有限定的核苷酸序列(即rRNA,tRNA和mRNA)或限定的氨基酸序列及其产生的生物学特性的生物学过程中合成其它聚合物和大分子的模板。因此,如果对应于该基因的mRNA的转录和翻译在细胞或其它生物系统中产生蛋白质,则该基因编码该蛋白质。The term "encoding" refers to the inherent property of a particular nucleotide sequence in a polynucleotide, such as a gene, cDNA or mRNA, as defined in a polynucleotide having a defined nucleotide sequence (ie, rRNA, tRNA and mRNA) or a defined amino acid sequence and its Templates for the synthesis of other polymers and macromolecules during biological processes that generate biological properties. Thus, a gene encodes a protein if the transcription and translation of the mRNA corresponding to the gene produces the protein in a cell or other biological system.
术语“表达调控元件”是指上调或下调一个或多个基因的表达的核苷酸序列。The term "expression regulatory element" refers to a nucleotide sequence that up-regulates or down-regulates the expression of one or more genes.
术语“调节元件”可以以“顺式”或“反式”起作用,并且通常以“顺式”起作用,即其激活位于调节元件所在的相同核酸分子(例如染色体)上的基因的表达。调节元件包括启动子、增强子、内含子、5’-非翻译区(5’-UTR,还被称为前导序列)或3’-UTR、转座子或终止子。The term "regulatory element" may function in "cis" or "trans", and is usually "cis", ie it activates the expression of a gene located on the same nucleic acid molecule (eg, chromosome) as the regulatory element. Regulatory elements include promoters, enhancers, introns, 5'-untranslated regions (5'-UTRs, also known as leader sequences) or 3'-UTRs, transposons or terminators.
术语“调节区”通常包括参与调控核酸分子(例如基因或靶基因)的转录的调节元件(regulatory elements),如启动子、增强子、内含子、5’-非翻译区(5’-UTR,还被称为前导序列)或3’-UTR、转座子、终止子所在的区域或其他非编码区。The term "regulatory region" generally includes regulatory elements such as promoters, enhancers, introns, 5'-untranslated regions (5'-UTRs) involved in regulating the transcription of nucleic acid molecules (eg, genes or target genes). , also known as the leader sequence) or 3'-UTR, transposons, regions where terminators are located, or other noncoding regions.
如本文中所使用的,术语“启动子”具有本领域技术人员公知的含义,其是指一段位于基因的上游能启动下游基因表达的非编码核苷酸序列。组成型(constitutive)启动子是这样的核苷酸序列:当其与编码或者限定基因产物的多核苷酸可操作地相连时,在细胞的大多数或者所有生理条件下,其导致细胞中基因产物的产生。诱导型启动子是这样的核苷酸序列,当可操作地与编码或者限定基因产物的多核苷酸相连时,基本上只有当对应于所述启动子的诱导物在细胞中存在时,其导致所述基因产物在细胞内产生。组织特异性启动子是这样的核苷酸序列:当可操作地与编码或者限定基因产物的多核苷酸相连时,基本上只有当细胞是该启动子对应的组织类型的细胞时,其才导致在细胞中产生基因产物。As used herein, the term "promoter" has the meaning well known to those skilled in the art and refers to a non-coding nucleotide sequence located upstream of a gene that initiates expression of a downstream gene. A constitutive promoter is a nucleotide sequence which, when operably linked to a polynucleotide encoding or defining the gene product, results in the gene product in a cell under most or all physiological conditions of the cell production. An inducible promoter is a nucleotide sequence that, when operably linked to a polynucleotide encoding or defining a gene product, results in substantially only when an inducer corresponding to the promoter is present in a cell. The gene product is produced intracellularly. A tissue-specific promoter is a nucleotide sequence that, when operably linked to a polynucleotide encoding or defining a gene product, results in substantially only when the cell is of the tissue type to which the promoter corresponds. The gene product is produced in the cell.
如本文中所使用的,术语“可操作地连接”旨在表示感兴趣的核苷酸序列以一种允许该核苷酸序列的表达的方式被连接至该一种或多种调控元件(例如,处于一种体外转录/翻译系统中或当该载体被引入到宿主细胞中时,处于该宿主细胞中)。As used herein, the term "operably linked" is intended to mean that the nucleotide sequence of interest is linked to the one or more regulatory elements (e.g., , in an in vitro transcription/translation system or in a host cell when the vector is introduced into the host cell).
术语“载体”是包含允许载体整合入宿主细胞基因组或在细胞内不依赖于基因组而自主复制的元件。该载体可能包含保证自我复制的任何元件。其通常携带不是细胞中心代谢的一部分的基因,并且通常是双链DNA的形式。载体的选择通常取决于载体与该载体待引入之宿主细胞的相容性。如果使用载体,则载体的选择取决于本领域技术人员众所周知的用于转化宿主细胞的方法。例如, 可以使用质粒载体。The term "vector" includes elements that allow the vector to integrate into the host cell genome or to replicate autonomously within the cell independent of the genome. The vector may contain any elements that ensure self-replication. It usually carries genes that are not part of the central metabolism of the cell, and is usually in the form of double-stranded DNA. The choice of vector will generally depend on the compatibility of the vector with the host cell into which the vector is to be introduced. If a vector is used, the choice of vector depends on methods well known to those skilled in the art for transforming host cells. For example, plasmid vectors can be used.
术语“宿主细胞”应理解为任何单细胞或多细胞生物,包括例如细菌如大肠杆菌,真菌如酵母(例如酿酒酵母)、霉菌(例如曲霉菌),植物细胞和植物等。The term "host cell" is understood to mean any unicellular or multicellular organism, including, for example, bacteria such as E. coli, fungi such as yeast (eg Saccharomyces cerevisiae), molds (eg Aspergillus), plant cells and plants, and the like.
术语“植物”应理解为能够进行光合作用的任何分化的多细胞生物,在包括处于任何成熟或发育阶段的作物植物,特别是单子叶或双子叶植物,蔬菜作物,包括洋蓟、球茎甘蓝、芝麻菜、韭葱、芦笋、莴苣(例如,结球莴苣、叶莴苣、长叶莴苣)、小白菜(bok choy)、黄肉芋、瓜类(例如,甜瓜、西瓜、克伦肖瓜(crenshaw)、白兰瓜、罗马甜瓜)、油菜作物(例如,球芽甘蓝、卷心菜、花椰菜、西兰花、羽衣甘蓝、无头甘蓝、大白菜、小白菜)、刺菜蓟、胡萝卜、洋白菜(napa)、秋葵、洋葱、芹菜、欧芹、鹰嘴豆、欧洲防风草、菊苣、胡椒、马铃薯、葫芦(例如,西葫芦、黄瓜、小西葫芦、倭瓜、南瓜)、萝卜、干球洋葱、芜菁甘蓝、紫茄子(也称为茄子)、婆罗门参、苣菜、青葱、苦苣、大蒜、菠菜、绿洋葱、倭瓜、绿叶菜类(greens)、甜菜(糖甜菜和饲料甜菜)、甘薯、唐莴苣、山葵、西红柿、芜菁、以及香辛料;水果和/或蔓生作物,如苹果、杏、樱桃、油桃、桃、梨、李子、西梅、樱桃、榅桲、杏仁、栗子、榛子、山核桃、开心果、胡桃、柑橘、蓝莓、博伊增莓(boysenberry)、小红莓、穗醋栗、罗甘莓、树莓、草莓、黑莓、葡萄、鳄梨、香蕉、猕猴桃、柿子、石榴、菠萝、热带水果、梨果、瓜、芒果、木瓜、以及荔枝;大田作物,如三叶草、苜蓿、月见草、白芒花、玉米/玉蜀黍(饲料玉米、甜玉米、爆米花)、啤酒花、荷荷芭、花生、稻、红花、小粒谷类作物(大麦、燕麦、黑麦、小麦等)、高粱、烟草、木棉、豆科植物(豆类、小扁豆、豌豆、大豆)、含油植物(油菜、芥菜、罂粟、橄榄、向日葵、椰子、蓖麻油植物、可可豆、落花生)、拟南芥属、纤维植物(棉花、亚麻、大麻、黄麻)、樟科(肉桂、莰酮)、或一种植物如咖啡、甘蔗、茶、以及天然橡胶植物;和/或花坛植物,如开花植物、仙人掌、肉质植物和/或观赏植物,以及树如森林(阔叶树和常绿树,如针叶树)、果树、观赏树、以及结坚果的树(nut-bearing tree)、以及灌木和其他苗木。The term "plant" is to be understood as any differentiated multicellular organism capable of photosynthesis, including crop plants at any stage of maturity or development, in particular monocotyledonous or dicotyledonous plants, vegetable crops including artichokes, cabbage, Arugula, leeks, asparagus, lettuce (eg, head lettuce, leaf lettuce, romaine), bok choy, yellow taro, melons (eg, melon, watermelon, crenshaw ), white melon, romaine melon), canola crops (e.g., Brussels sprouts, cabbage, cauliflower, broccoli, kale, kale, Chinese cabbage, pak choi), spinach, carrots, napa, Okra, onions, celery, parsley, chickpeas, parsnips, chicory, peppers, potatoes, gourds (e.g., zucchini, cucumbers, zucchini, zucchini, squash), radishes, dried bulb onions, rutabagas, Purple eggplant (also called eggplant), salsify, endive, shallots, endive, garlic, spinach, green onions, zucchini, greens, beets (sugar beets and fodder beets), sweet potatoes, chard, Wasabi, tomatoes, turnips, and spices; fruits and/or trailing crops such as apples, apricots, cherries, nectarines, peaches, pears, plums, prunes, cherries, quinces, almonds, chestnuts, hazelnuts, pecans, Pistachios, walnuts, citrus, blueberries, boysenberry, cranberries, currant, loganberry, raspberry, strawberry, blackberry, grape, avocado, banana, kiwi, persimmon, pomegranate, pineapple , tropical fruits, pomes, melons, mangoes, papayas, and lychees; field crops such as clover, alfalfa, evening primrose, jasmine, corn/maize (fodder corn, sweet corn, popcorn), hops, lotus Barley, peanuts, rice, safflower, small grain crops (barley, oats, rye, wheat, etc.), sorghum, tobacco, kapok, legumes (beans, lentils, peas, soybeans), oily plants (rapese, mustard, poppy, olive, sunflower, coconut, castor oil plants, cocoa beans, groundnuts), Arabidopsis, fibrous plants (cotton, flax, hemp, jute), lauraceae (cinnamon, camphor), or a plant such as coffee, sugar cane, tea, and natural rubber plants; and/or flower bed plants, such as flowering plants, cacti, succulents and/or ornamentals, and trees such as forests (broadleaf and evergreen, such as conifers), fruit trees, ornamental Trees, and nut-bearing trees, as well as shrubs and other seedlings.
术语“植物组织”或“植物部分”包括植物细胞、原生质体、植物组织培养物、植物愈伤组织、植物块以及植物胚、花粉、胚珠、种子、叶、茎、花、枝、幼苗、果实、核、穗、根、根尖、花药等。The term "plant tissue" or "plant part" includes plant cells, protoplasts, plant tissue cultures, plant callus, plant pieces as well as plant embryos, pollen, ovules, seeds, leaves, stems, flowers, shoots, seedlings, fruits , nucleus, ear, root, root tip, anther, etc.
术语“植物细胞”应理解为来自或发现于植物的任何细胞,其能够形成例如:未分化组织如愈伤组织,分化组织如胚胎,植物的组成部分,植物或种子。The term "plant cell" is to be understood as any cell from or found in a plant, which is capable of forming, for example: undifferentiated tissue such as callus, differentiated tissue such as embryos, components of plants, plants or seeds.
术语“基因编辑”技术包括CRISPR技术、TALEN技术、ZFN技术。CRISPR技术是指成簇、规律间隔的短回文重复序列(Clustered regularly interspaced short palindromic repeats),其来自微生物的免疫系统。其中 基因编辑工具包括guideRNA、Cas蛋白(如Cas9、Cpf1、Cas12b等)。TALEN技术中所指的基因编辑工具是可以切割特定DNA序列的限制酶,其包括一个TAL效应子DNA结合结构域和一个DNA切割结构域。ZFN技术中所指的基因编辑工具也是可以切割特定DNA序列的限制酶,其包括一个锌指DNA结合结构域与一个DNA切割结构域。本领域技术人员熟知,将编码基因编辑工具的核苷酸及其他调控元件构建于适宜的载体中,再转化细胞,可以实现对细胞内基因组的编辑,所述编辑的类型包括基因敲除、插入、碱基编辑。The term "gene editing" technology includes CRISPR technology, TALEN technology, ZFN technology. CRISPR technology refers to clustered regularly interspaced short palindromic repeats (Clustered regularly interspaced short palindromic repeats), which are derived from the immune system of microorganisms. Among them, gene editing tools include guideRNA, Cas proteins (such as Cas9, Cpf1, Cas12b, etc.). Gene editing tools referred to in TALEN technology are restriction enzymes that can cut specific DNA sequences and include a TAL effector DNA binding domain and a DNA cleavage domain. Gene editing tools referred to in ZFN technology are also restriction enzymes that can cut specific DNA sequences, including a zinc finger DNA binding domain and a DNA cleavage domain. It is well known to those skilled in the art that by constructing nucleotides encoding gene editing tools and other regulatory elements in a suitable vector, and then transforming cells, the editing of the intracellular genome can be achieved, and the types of editing include gene knockout, insertion , base editing.
本发明中适用的载体包括可从商业渠道获得的质粒,例如但不限于:pBR322(ATCC37017),pKK223-3(Pharmacia Fine Chemicals,Uppsala,Sweden),GEM1(Promega Biotec,Madison,WI,USA)pQE70,pQE60,pQE-9(Qiagen),pD10,psiX174pBluescript II KS,pNH8A,pNH16a,pNH18A,pNH46A(Stratagene),ptrc99a,pKK223-3,pKK233-3,pDR540,pRIT5(Pharmacia),pKK232-8,pCM7,pSV2CAT,pOG44,pXT1,pSG(Stratagene),pSVK3,pBPV,pMSG,和pSVL(Pharmacia)等。Vectors suitable for use in the present invention include commercially available plasmids such as but not limited to: pBR322 (ATCC37017), pKK223-3 (Pharmacia Fine Chemicals, Uppsala, Sweden), GEM1 (Promega Biotec, Madison, WI, USA) pQE70 , pQE60, pQE-9 (Qiagen), pD10, psiX174, pBluescript II KS, pNH8A, pNH16a, pNH18A, pNH46A (Stratagene), ptrc99a, pKK223-3, pKK233-3, pDR540, pRIT5 (Pharmacia), pKK232-8, pCM7, pSV2CAT, pOG44, pXT1, pSG (Stratagene), pSVK3, pBPV, pMSG, and pSVL (Pharmacia), among others.
本发明的核酸序列、核酸构建体或表达载体可以通过多种技术导入宿主细胞,包括转化、转染、转导、病毒感染、基因枪或Ti-质粒介导的基因传递,以及钙磷酸盐转染、DEAE-葡聚糖介导的转染、脂转染或电穿孔等。The nucleic acid sequences, nucleic acid constructs or expression vectors of the invention can be introduced into host cells by a variety of techniques, including transformation, transfection, transduction, viral infection, gene gun or Ti-plasmid mediated gene delivery, and calcium phosphate transfection transfection, DEAE-dextran-mediated transfection, lipofection or electroporation, etc.
在本发明的生产方法中,用本领域众所周知的方法将所述细胞培养于适于所述多肽产生的营养培养基上。若所述多肽被分泌入营养培养基中,则可直接从培养基中回收该多肽。若所述多肽不分泌到培养基中,则可从细胞裂解物中回收它。In the production method of the present invention, the cells are cultured on a nutrient medium suitable for the production of the polypeptide using methods well known in the art. If the polypeptide is secreted into the nutrient medium, the polypeptide can be recovered directly from the medium. If the polypeptide is not secreted into the medium, it can be recovered from cell lysates.
表1.不同表达调控元件的序列Table 1. Sequences of different expression regulatory elements
seq IDseq ID 名称name 序列sequence
11 A1A1 ACGTAAGCGATGACGTACGTAAGCGATGACGT
22 A2A2 ACGTAAGCAATGACGTACGTAAGCAATGACGT
33 A3A3 ACGTAAGCACTGACGTACGTAAGCACTGACGT
44 A4A4 ACGTAAGCGCTGACGTACGTAAGCGCTGACGT
55 A5A5 ACGTAAGCGATTACGTACGTAAGCGATTACGT
66 A6A6 ACGTAAGCAATTACGTACGTAAGCAATTACGT
77 A7A7 ACGTAAGCACTTACGTACGTAAGCACTTACGT
88 A8A8 ACGTAAGCGCTTACGTACGTAAGCGCTTACGT
99 B1B1 ACGTAAGGGATGACGTACGTAAGGGATGACGT
1010 B2B2 ACGTAAGGAATGACGTACGTAAGGAATGACGT
1111 B3B3 ACGTAAGGACTGACGTACGTAAGGACTGACGT
1212 B4B4 ACGTAAGGGCTGACGTACGTAAGGGCTGACGT
1313 B5B5 ACGTAAGGGATTACGTACGTAAGGGATTACGT
1414 B6B6 ACGTAAGGAATTACGTACGTAAGGAATTACGT
1515 B7B7 ACGTAAGGACTTACGTACGTAAGGACTTACGT
1616 B8B8 ACGTAAGGGCTTACGTACGTAAGGGCTTACGT
1717 C1C1 ACGCAAGCGATGACGTACGCAAGCGATGACGT
1818 C2C2 ACGCAAGCAATGACGTACGCAAGCAATGACGT
1919 C3C3 ACGCAAGCACTGACGTACGCAAGCACTGACGT
2020 C4C4 ACGCAAGCGCTGACGTACGCAAGCGCTGACGT
21twenty one C5C5 ACGCAAGCGATTACGTACGCAAGCGATTACGT
22twenty two C6C6 ACGCAAGCAATTACGTACGCAAGCAATTACGT
23twenty three C7C7 ACGCAAGCACTTACGTACGCAAGCACTTACGT
24twenty four C8C8 ACGCAAGCGCTTACGTACGCAAGCGCTTACGT
2525 D1D1 ACGCAAGGGATGACGTACGCAAGGGATGACGT
2626 D2D2 ACGCAAGGAATGACGTACGCAAGGAATGACGT
2727 D3D3 ACGCAAGGACTGACGTACGCAAGGACTGACGT
2828 D4D4 ACGCAAGGGCTGACGTACGCAAGGGCTGACGT
2929 D5D5 ACGCAAGGGATTACGTACGCAAGGGATTACGT
3030 D6D6 ACGCAAGGAATTACGTACGCAAGGAATTACGT
3131 D7D7 ACGCAAGGACTTACGTACGCAAGGACTTACGT
3232 D8D8 ACGCAAGGGCTTACGTACGCAAGGGCTTACGT
3333 E1E1 ACGTAAGCGATGACGCACGTAAGCGATGACGC
3434 E2E2 ACGTAAGCAATGACGCACGTAAGCAATGACGC
3535 E3E3 ACGTAAGCACTGACGCACGTAAGCACTGACGC
3636 E4E4 ACGTAAGCGCTGACGCACGTAAGCGCTGACGC
3737 E5E5 ACGTAAGCGATTACGCACGTAAGCGATTACGC
3838 E6E6 ACGTAAGCAATTACGCACGTAAGCAATTACGC
3939 E7E7 ACGTAAGCACTTACGCACGTAAGCACTTACGC
4040 E8E8 ACGTAAGCGCTTACGCACGTAAGCGCTTACGC
4141 F1F1 ACGTAAGGGATGACGCACGTAAGGGATGACGC
4242 F2F2 ACGTAAGGAATGACGCACGTAAGGAATGACGC
4343 F3F3 ACGTAAGGACTGACGCACGTAAGGACTGACGC
4444 F4F4 ACGTAAGGGCTGACGCACGTAAGGGCTGACGC
4545 F5F5 ACGTAAGGGATTACGCACGTAAGGGATTACGC
4646 F6F6 ACGTAAGGAATTACGCACGTAAGGAATTACGC
4747 F7F7 ACGTAAGGACTTACGCACGTAAGGACTTACGC
4848 F8F8 ACGTAAGGGCTTACGCACGTAAGGGCTTACGC
4949 G1G1 ACGCAAGCGATGACGCACGCAAGCGATGACGC
5050 G2G2 ACGCAAGCAATGACGCACGCAAGCAATGACGC
5151 G3G3 ACGCAAGCACTGACGCACGCAAGCACTGACGC
5252 G4G4 ACGCAAGCGCTGACGCACGCAAGCGCTGACGC
5353 G5G5 ACGCAAGCGATTACGCACGCAAGCGATTACGC
5454 G6G6 ACGCAAGCAATTACGCACGCAAGCAATTACGC
5555 G7G7 ACGCAAGCACTTACGCACGCAAGCACTTACGC
5656 G8G8 ACGCAAGCGCTTACGCACGCAAGCGCTTACGC
5757 H1H1 ACGCAAGGGATGACGCACGCAAGGGATGACGC
5858 H2H2 ACGCAAGGAATGACGCACGCAAGGAATGACGC
5959 H3H3 ACGCAAGGACTGACGCACGCAAGGACTGACGC
6060 H4H4 ACGCAAGGGCTGACGCACGCAAGGGCTGACGC
6161 H5H5 ACGCAAGGGATTACGCACGCAAGGGATTACGC
6262 H6H6 ACGCAAGGAATTACGCACGCAAGGAATTACGC
6363 H7H7 ACGCAAGGACTTACGCACGCAAGGACTTACGC
6464 H8H8 ACGCAAGGGCTTACGCACGCAAGGGCTTACGC
本发明的主要优点:The main advantages of the present invention:
1、本发明筛选出了一组表达调控元件。1. The present invention screened out a group of expression control elements.
2、将本发明表达调控元件与目标基因连接可以明显提高目标基因的表达量。2. Connecting the expression control element of the present invention to the target gene can significantly increase the expression level of the target gene.
附图说明Description of drawings
图1.筛选载体组成,图示增强子为待筛选的64个表达调控元件序列,Mini35S为改造后的转录激活能力较弱的启动子,GUS是β-葡萄糖苷酸酶基因(β-glucuronidase)。Figure 1. The composition of the screening vector, the enhancer is the 64 expression control element sequences to be screened, Mini35S is the modified promoter with weak transcriptional activation ability, and GUS is the β-glucuronidase gene (β-glucuronidase) .
图2A-2F中,阳性对照为以mini35S启动的Gus质粒,阴性对照为以改造后的mini35S启动的Gus质粒。In Figures 2A-2F, the positive control is the Gus plasmid started with mini35S, and the negative control is the Gus plasmid started with the modified mini35S.
图2A为针对A1-A8表达调控元件活性的检测。Figure 2A is an assay for the activity of A1-A8 expression regulatory elements.
图2B为针对B1-B8表达调控元件活性的检测。Figure 2B is an assay for the activity of B1-B8 expression regulatory elements.
图2C为针对C1-C8、D1-D8表达调控元件活性的检测。Figure 2C is the detection of the activity of C1-C8, D1-D8 expression regulatory elements.
图2D为针对E1-E8表达调控元件活性的检测。Figure 2D is an assay for the activity of E1-E8 expression regulatory elements.
图2E为针对F1-F8表达调控元件活性的检测。Figure 2E is an assay for the activity of F1-F8 expression regulatory elements.
图2F为针对G1-G8、H1-H8表达调控元件活性的检测。Figure 2F is the detection of G1-G8, H1-H8 expression regulatory element activity.
图3.相对荧光测量载体组成,图示增强子为待测定的5个表达调控元件序列,Mini35S为改造后的转录激活能力较弱的启动子,mCherry是红色荧光基团,2×35s是正常转录激活能力的启动子,GPF是绿色荧光蛋白,Nos和E9是常见的终止子。Figure 3. The composition of the relative fluorescence measurement vector, the enhancer is the sequence of the five expression control elements to be determined, Mini35S is a modified promoter with weak transcriptional activation ability, mCherry is a red fluorescent group, and 2×35s is normal The promoter of transcriptional activation ability, GPF is green fluorescent protein, Nos and E9 are common terminators.
图4.稳定含有不同表达调控元件质粒的转化苗的Gus染色。WT未做任何处理拟南芥苗,mini35S是以改造后的mini35S的启动子为启动子的转化苗,为阴性对照;35S是以35S启动子为启动子的转化苗,是阳性对照(图中“1301”);其他3株转化苗分别在改造后的mini35调节区添加F4表达调控元件、F5表达调控元件和F8表达调控元件,用于验证F4表达调控元件、F5表达调控元件和F8表达调控元件的功能。Figure 4. Gus staining of transformed seedlings stably containing plasmids with different expression regulatory elements. WT did not do any treatment of Arabidopsis thaliana seedlings, mini35S is a transformed seedling with the transformed mini35S promoter as the promoter, and it is a negative control; 35S is a transformed seedling with the 35S promoter as a promoter, which is a positive control (Fig. "1301"); the other 3 transformed seedlings were respectively added with F4 expression control elements, F5 expression control elements and F8 expression control elements in the modified mini35 regulatory region to verify the F4 expression control elements, F5 expression control elements and F8 expression control elements function of the element.
实施方式Implementation
下面结合实施例对本发明做进一步的说明,以下所述,仅是对本发明的较佳实施例而已,并非对本发明做其他形式的限制,任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更为同等变化的等效实施例。凡是未脱离本发明方案内容,依据本发明的技术实质对以下实施例所做的任何简单修改或等同变化,均落在本发明的保护范围内。The present invention will be further described below in conjunction with the embodiments. The following descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention in other forms. Changes to equivalent embodiments with equivalent changes. Any simple modifications or equivalent changes made to the following embodiments according to the technical essence of the present invention without departing from the content of the solution of the present invention fall within the protection scope of the present invention.
实施例1、对64个序列进行筛选Example 1. Screening of 64 sequences
构建pCAMBIA1301-mini35S(82bp)-GUS筛选质粒,其中mini35S(82bp)启动子的转录激活能力较弱。在该被mini35s(82bp)的调节区连接被筛选表达调控元件后,若GUS的表达量有明显的提升则说明该表达调控元件有提高基因表达的能力。The pCAMBIA1301-mini35S(82bp)-GUS screening plasmid was constructed, in which the mini35S(82bp) promoter has weak transcriptional activation ability. After the regulatory region of mini35s (82bp) is connected to the screened expression regulatory element, if the expression level of GUS is significantly increased, it indicates that the expression regulatory element has the ability to improve gene expression.
将野生型增强子序列根据其不保守位点的序列扩展为64条(分组编号为A-H,共计8组,每组内以1-8依次编号,名称及序列如表1所示)。将64条表达调控元件序列连接至的pCAMBIA1301-mini35S(82bp)-GUS筛选质粒,构成64个不同的待筛选质粒,其主要元件的连接方式如图1所示,其中待筛选的表达调控元件A1和mini35s(82bp)连接后的序列为
Figure PCTCN2021126562-appb-000001
Figure PCTCN2021126562-appb-000002
(下划线标注的为A1,加粗斜体标注的是mini35s(82bp),TATA box和A1之间相隔75bp),其他表达调控元件添加方式与A1一致。
The wild-type enhancer sequence was expanded to 64 according to the sequence of its non-conserved site (the group number is AH, a total of 8 groups, each group is numbered 1-8 in sequence, the names and sequences are shown in Table 1). The pCAMBIA1301-mini35S(82bp)-GUS screening plasmids connected to 64 expression control element sequences constitute 64 different plasmids to be screened. The sequence after connecting with mini35s (82bp) is
Figure PCTCN2021126562-appb-000001
Figure PCTCN2021126562-appb-000002
(A1 is underlined, mini35s (82bp) is marked in bold italics, and the interval between TATA box and A1 is 75bp), and other expression control elements are added in the same way as A1.
将含有待筛选序列的质粒进行原生质体转化,之后进行GUS染色:Protoplast transformation was performed on the plasmid containing the sequence to be screened, followed by GUS staining:
(1)每10ug对应质粒,加入200ul原生质体(大约4*10 5细胞),再加入 220ul新配的PEG溶液,混匀,室温避光放置10~20分钟诱导转化; (1) For every 10ug of the corresponding plasmid, add 200ul of protoplasts (about 4 *105 cells), then add 220ul of the newly prepared PEG solution, mix well, and place at room temperature in the dark for 10-20 minutes to induce transformation;
(2)诱导转化结束后缓慢加880ul W5溶液,轻轻颠倒混匀,250g水平离心3分钟,弃上清;(2) Slowly add 880ul of W5 solution after induced transformation, gently invert and mix, centrifuge horizontally at 250g for 3 minutes, and discard the supernatant;
(3)加1ml WI溶液重悬,转移到六孔板中(已预先加入1ml WI溶液)室温(或28℃)暗处培养6~16小时。取出后对原生质体进行GUS染色,根据染色结果挑选具有转录增强活性的元件。(3) Add 1ml of WI solution to resuspend, transfer to a six-well plate (1ml of WI solution has been added in advance) and cultivate in the dark at room temperature (or 28°C) for 6-16 hours. After removal, the protoplasts were stained with GUS, and elements with transcriptional enhancing activity were selected according to the staining results.
图2A-2F中,阳性对照为以mini35S启动的Gus质粒,阴性对照为以改造后的mini35S(82bp)启动的Gus质粒,mini35S启动子原本能正常的启动Gus基因的表达,但是改造后基本失去启动子活性。如果在改造后的mini35S(82bp)前添加表达调控元件后观察到更明显的蓝色,即表明该表达调控元件确有增强活性。In Figures 2A-2F, the positive control is the Gus plasmid started with mini35S, and the negative control is the Gus plasmid started with the modified mini35S (82bp). The mini35S promoter can normally start the expression of the Gus gene, but it is basically lost after the transformation. promoter activity. If a more obvious blue color is observed after adding the expression control element before the modified mini35S (82bp), it indicates that the expression control element does have enhanced activity.
如图2A所示,A2、A5、A7、A8可以显著提高GUS的表达。As shown in Figure 2A, A2, A5, A7, and A8 could significantly increase the expression of GUS.
如图2B所示,B2、B4可以显著提高GUS的表达。As shown in Figure 2B, B2 and B4 could significantly increase the expression of GUS.
如图2C所示,C1、C4、C7、C8、D4可以显著提高GUS的表达。As shown in Figure 2C, C1, C4, C7, C8, D4 could significantly increase the expression of GUS.
如图2D所示,E1可以显著提高GUS的表达。As shown in Figure 2D, E1 could significantly increase the expression of GUS.
如图2E所示,F3、F4、F5、F8可以显著提高GUS的表达。As shown in Figure 2E, F3, F4, F5, and F8 could significantly increase the expression of GUS.
如图2F所示,G1、G3、G7可以显著提高GUS的表达。As shown in Figure 2F, G1, G3, and G7 could significantly increase the expression of GUS.
综上,通过上述实验,筛选到了19个可以增强GUS表达的表达调控元件,A2、A5、A7、A8、B2、B4、C1、C4、C7、C8、D4、E1、F3、F4、F5、F8、G1、G3、G7,序列依次如SEQ ID NO.:2、SEQ ID NO.:5、SEQ ID NO.:7、SEQ ID NO.:8、SEQ ID NO.:10、SEQ ID NO.:12、SEQ ID NO.:17、SEQ ID NO.:20、SEQ ID NO.:23、SEQ ID NO.:24、SEQ ID NO.:28、SEQ ID NO.:33、SEQ ID NO.:43、SEQ ID NO.:44、SEQ ID NO.:45、SEQ ID NO.:48、SEQ ID NO.:49、SEQ ID NO.:51或SEQ ID NO.:55中所示。In summary, through the above experiments, 19 expression regulatory elements that can enhance the expression of GUS were screened, A2, A5, A7, A8, B2, B4, C1, C4, C7, C8, D4, E1, F3, F4, F5, F8, G1, G3, G7, sequence as SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.:8, SEQ ID NO.:10, SEQ ID NO. :12, SEQ ID NO.:17, SEQ ID NO.:20, SEQ ID NO.:23, SEQ ID NO.:24, SEQ ID NO.:28, SEQ ID NO.:33, SEQ ID NO.: 43, SEQ ID NO.:44, SEQ ID NO.:45, SEQ ID NO.:48, SEQ ID NO.:49, SEQ ID NO.:51 or SEQ ID NO.:55.
实施例2、对筛选出的19个序列进一步验证Example 2. Further verification of the 19 sequences screened out
挑选上述实施例中的表达调控元件D4、E1、F4、F5和F8,分别与以mini35(82bp)启动的mCherry荧光基团进行连接,载体上还包括以35S启动子启动的GFP基因,构成相对荧光测量载体。在该载体上按图3所示的方式连接待验证的表达调控元件,增强子与mini35s(82bp)的连接方式与实施例1相同,将构建好的5个相对荧光测量载体和一个阴性对照(不包含表达调控元件)进行原生质体转化,转化24小时后,在荧光下测量,以标准化后的GFP荧光强度作为参比,测定相对荧光强度,结果如表2所示:图示增强子为待测定的5个表达调控元件序列,Mini35S为改造后的转录激活能力较弱的启动子Mini35S(82bp),mCherry是红色荧光基团,2X 35s是正常转录激活能力的启动子, GPF是绿色荧光蛋白,Nos和E9是常见的终止子。The expression control elements D4, E1, F4, F5 and F8 in the above-mentioned embodiment are selected and connected with the mCherry fluorophore started with mini35 (82bp) respectively, and the GFP gene started with the 35S promoter is also included on the carrier, forming a relative Fluorescence measurement carrier. The expression control element to be verified is connected to the vector in the manner shown in Figure 3, and the connection between the enhancer and mini35s (82bp) is the same as that in Example 1, and five constructed relative fluorescence measurement vectors and a negative control ( Protoplast transformation was performed 24 hours after transformation, and the relative fluorescence intensity was measured with the normalized GFP fluorescence intensity as a reference. The results are shown in Table 2: The sequences of the five expression control elements determined, Mini35S is the modified promoter Mini35S (82bp) with weak transcriptional activation ability, mCherry is the red fluorescent group, 2X 35s is the promoter with normal transcriptional activation ability, GPF is the green fluorescent protein , Nos and E9 are common terminators.
相对荧光强度=FmCherry/FGFPRelative fluorescence intensity = FmCherry/FGFP
FmCherry为三个不同视野中所有红色荧光蛋白(mCherry)发光强度的平均值;FGFP为三个不同视野中所有绿色荧光蛋白(GFP)发光强度的平均值。FmCherry is the average of all red fluorescent protein (mCherry) luminescence intensities in three different fields of view; FGFP is the average of all green fluorescent protein (GFP) luminescence intensities in three different fields of view.
表2.D4、E1、F4、F5和F8的相对荧光强度Table 2. Relative fluorescence intensities of D4, E1, F4, F5 and F8
编号Numbering 表达调控元件名称Expression regulatory element name 相对荧光强度(1×)Relative fluorescence intensity (1×)
11 D4D4 1.841.84
22 E1E1 2.022.02
33 F4F4 1.961.96
44 F5F5 1.981.98
55 F8F8 2.002.00
66 none 00
如表2所示,包含D4、E1、F4、F5和F8表达调控元件的载体,相对有不包含表达调控元件的载体,都测得明显高mCherry荧光,相对荧光强度也更高,证明此5个表达调控元件确有较强的提高目标基因表达的作用。As shown in Table 2, the vectors containing D4, E1, F4, F5 and F8 expression control elements have significantly higher mCherry fluorescence and higher relative fluorescence intensity than those without expression control elements, which proves that 5 Each expression regulatory element does have a strong effect on improving the expression of the target gene.
实施例3、对多拷贝表达调控元件效果的验证Example 3. Verification of the effect of multi-copy expression regulatory elements
分别构建含有3个拷贝F4、3个拷贝F5表达调控元件的载体双荧光检测载体。每个表达调控元件首尾相接,插入在mini35S(82bp)启动子上游75bp。插入3个拷贝的F4后,mini35S(82bp)启动子和增强子的序列为:
Figure PCTCN2021126562-appb-000003
Figure PCTCN2021126562-appb-000004
(下划线标注的为3个拷贝的F4,加粗斜体标注的是mini35s(82bp),TATA box和最下游的F4之间相隔75bp),3个拷贝F5表达调控元件添加方式与F4一致。
The vector double fluorescence detection vector containing 3 copies of F4 and 3 copies of F5 expression control elements was constructed respectively. Each expression regulatory element was placed end to end and inserted 75 bp upstream of the mini35S (82 bp) promoter. After inserting 3 copies of F4, the sequences of the mini35S (82bp) promoter and enhancer are:
Figure PCTCN2021126562-appb-000003
Figure PCTCN2021126562-appb-000004
(The underlined is 3 copies of F4, the bold italic is marked with mini35s (82bp), the TATA box and the most downstream F4 are separated by 75bp), the 3 copies of F5 expression regulatory elements are added in the same way as F4.
转化原生质体。24小时后,在荧光下测量,以标准化后的GFP荧光强度作为参比,测定相对荧光强度,增加表达调控元件数量后,相对荧光强度均明显提高,且比1个拷贝的表达调控元件效果更强,结果如表3所示。Transform protoplasts. 24 hours later, measured under fluorescence, with the normalized GFP fluorescence intensity as a reference, to determine the relative fluorescence intensity, after increasing the number of expression regulatory elements, the relative fluorescence intensity was significantly improved, and the effect was better than that of one copy of the expression regulatory element. strong, and the results are shown in Table 3.
表3.F4、F5的相对荧光强度Table 3. Relative fluorescence intensity of F4 and F5
Figure PCTCN2021126562-appb-000005
Figure PCTCN2021126562-appb-000005
实施例4、对本发明表达调控元件增强其他启动子效果的验证Example 4. Verification of the expression control element of the present invention enhancing the effect of other promoters
扩增319bp辣椒中的PUN1核心启动子,通过BstEII酶切,将F4、F5和F8分别融合于辣椒素合酶基因PUN1的启动子TATA box上游71bp处,连接后的启动子和增强子序列为
Figure PCTCN2021126562-appb-000006
Figure PCTCN2021126562-appb-000007
(下划线标注的为3个拷贝的F4,加粗斜体标注的是PUN1核心启动子);其他表达调控元件添加方式与上述一致。之后将改造的启动子与mCherry融合,形成pCAMBIA1301-pPUN1(enhancer)::mCherry-Tnos-35S::GFP-TE9双荧光载体。通过PEG介导的方法,将载体转入辣椒胎座原生质体,测定并计算相对荧光强度。
The PUN1 core promoter in 319bp pepper was amplified, and F4, F5 and F8 were respectively fused to the TATA box upstream of the promoter of the capsaicin synthase gene PUN1 by BstEII digestion. The connected promoter and enhancer sequences were
Figure PCTCN2021126562-appb-000006
Figure PCTCN2021126562-appb-000007
(The underlined is 3 copies of F4, and the bold italics is the PUN1 core promoter); other expression control elements are added in the same manner as above. Then the modified promoter was fused with mCherry to form pCAMBIA1301-pPUN1(enhancer)::mCherry-Tnos-35S::GFP-TE9 dual fluorescent vector. The vector was transformed into capsicum placenta protoplasts by PEG-mediated method, and the relative fluorescence intensity was measured and calculated.
实验结果表明,连接表达调控元件后,mCherry的表达量相较于不含表达调控元件的对照有所提升。The experimental results showed that the expression of mCherry was increased after the expression regulatory elements were connected, compared with the control without the expression regulatory elements.
实施例5、在稳定转化的植物中验证本发明表达调控元件基因表达调控的Example 5. Verification of the expression regulation of the expression regulatory element of the present invention in stably transformed plants 效果Effect
将携带有F4、F5和F8表达调控元件的pCAMBIA1301-mini35S(enhancer)::GUS载体以及pCAMBIA1301-mini35S::GUS阴性对照和pCAMBIA1301-35S::GUS阳性对照,通过花序侵染法分别转化拟南芥。对T1代转基因拟南芥进行GUS染色,进一步确定了F4、F5、F8元件具有较好的表达调控元件活性。The pCAMBIA1301-mini35S(enhancer)::GUS vector carrying the expression regulatory elements of F4, F5 and F8, as well as the pCAMBIA1301-mini35S::GUS negative control and pCAMBIA1301-35S::GUS positive control, were transformed into Pseudomonas by inflorescence infection method. mustard. GUS staining was performed on T1 transgenic Arabidopsis, and it was further confirmed that F4, F5 and F8 elements have good expression regulation element activity.
结果如图4所示,WT未做任何处理,无Gus显色,阳性对照使用常见35S启动子,Gus显色明显,改造后的mini35S为阴性对照,无Gus显色,在改造后的mini35调节区添加F4表达调控元件、F5表达调控元件和F8表达调控元件都能观察到一定程度的Gus显色,连接方式如实施例1一致,说明F4表达调控元件、F5表达调控元件和F8表达调控元件都有增强启动子活性的功能。The results are shown in Figure 4. WT did not do any treatment, no Gus color development, the positive control used the common 35S promoter, Gus color development was obvious, the modified mini35S was a negative control, no Gus color development, adjusted in the modified mini35 If the F4 expression control element, the F5 expression control element and the F8 expression control element are added to the region, a certain degree of Gus coloration can be observed. All have the function of enhancing promoter activity.
实施例6、通过基因编辑的方式在目标基因前插入本发明的表达调控元件Example 6. Insertion of the expression control element of the present invention before the target gene by gene editing
通过基因编辑的方式在目标基因的调节区插入本发明的表达调控元件,通过RT-PCR和western的方式检测该基因的表达量,可以明显检测到表达量提升。The expression control element of the present invention is inserted into the regulatory region of the target gene by means of gene editing, and the expression level of the gene is detected by RT-PCR and western methods, and an increase in the expression level can be obviously detected.

Claims (10)

  1. 一种表达调控元件,其特征在于,所述表达调控元件包含SEQ ID NO.:2、SEQ ID NO.:5、SEQ ID NO.:7、SEQ ID NO.:8、SEQ ID NO.:10、SEQ ID NO.:12、SEQ ID NO.:17、SEQ ID NO.:20、SEQ ID NO.:23、SEQ ID NO.:24、SEQ ID NO.:28、SEQ ID NO.:33、SEQ ID NO.:43、SEQ ID NO.:44、SEQ ID NO.:45、SEQ ID NO.:48、SEQ ID NO.:49、SEQ ID NO.:51或SEQ ID NO.:55中任一所示的多核苷酸序列或与其互补的多核苷酸序列。An expression control element, characterized in that the expression control element comprises SEQ ID NO.:2, SEQ ID NO.:5, SEQ ID NO.:7, SEQ ID NO.:8, SEQ ID NO.:10 , SEQ ID NO.:12, SEQ ID NO.:17, SEQ ID NO.:20, SEQ ID NO.:23, SEQ ID NO.:24, SEQ ID NO.:28, SEQ ID NO.:33, Any of SEQ ID NO.:43, SEQ ID NO.:44, SEQ ID NO.:45, SEQ ID NO.:48, SEQ ID NO.:49, SEQ ID NO.:51 or SEQ ID NO.:55 A polynucleotide sequence shown or a polynucleotide sequence complementary thereto.
  2. 一种核酸构建物,其特征在于,所述核酸构建物含有权利要求1所述的表达调控元件以及与之可操作连接的调节元件或目标基因。A nucleic acid construct, characterized in that the nucleic acid construct contains the expression regulatory element of claim 1 and a regulatory element or target gene operably linked to it.
  3. 一种载体,其特征在于,所述载体包含权利要求1所述的表达调控元件或权利要求2所述的核酸构建物。A vector, characterized in that the vector comprises the expression control element of claim 1 or the nucleic acid construct of claim 2.
  4. 一种宿主细胞,其特征在于,所述宿主细胞含有权利要求1所述的表达调控元件、权利要求2所述的核酸构建物、或权利要求3所述的载体。A host cell, characterized in that the host cell contains the expression control element of claim 1, the nucleic acid construct of claim 2, or the vector of claim 3.
  5. 一种调控目标基因表达的方法,其特征在于,所述方法包括利用权利要求1所述的表达调控元件调控所述目标基因表达的步骤。A method for regulating the expression of a target gene, characterized in that the method comprises the step of regulating the expression of the target gene by using the expression control element of claim 1 .
  6. 一种调控目标基因在植物细胞中的表达的方法,所述方法包括利用权利要求1所述的表达调控元件调控目标基因表达的步骤。A method for regulating the expression of a target gene in a plant cell, the method comprising the step of regulating the expression of the target gene using the expression control element described in claim 1.
  7. 一种制备目标基因表达量提高的植物细胞、植物组织、植物部分或植物的方法,所述方法包括在植物细胞、植物组织、植物部分或植物中利用权利要求1所述的表达调控元件提高目标基因表达的步骤。A method for preparing a plant cell, plant tissue, plant part or plant with increased expression of a target gene, the method comprising utilizing the expression control element according to claim 1 to improve the target gene in the plant cell, plant tissue, plant part or plant steps of gene expression.
  8. 如权利要求5-7任一所述的方法,其特征在于,所述方法包 括在目标基因的调节区中引入权利要求1所述的表达调控元件的步骤。The method according to any one of claims 5-7, wherein the method comprises the step of introducing the expression control element according to claim 1 in the regulatory region of the target gene.
  9. 如权利要求8所述的方法,其特征在于,在目标基因的调节区中引入权利要求1所述的表达调控元件,通过以下任一方式实现:The method of claim 8, wherein the expression control element of claim 1 is introduced into the regulatory region of the target gene, which is achieved by any of the following methods:
    (1)通过对目标基因的调节区中的1个或多个核酸进行编辑从而使得调节区中包含有权利要求1所述的表达调控元件;(1) by editing one or more nucleic acids in the regulatory region of the target gene so that the regulatory region contains the expression control element of claim 1;
    (2)在目标基因的调节区中插入权利要求1所述的表达调控元件从而使得调节区中包含有权利要求1所述的表达调控元件。(2) inserting the expression control element of claim 1 into the regulatory region of the target gene so that the expression control element of claim 1 is included in the regulatory region.
  10. 如权利要求1所述的表达调控元件、权利要求2所述的核酸构建物、权利要求3所述的载体或权利要求4所述的宿主细胞在以下a)-e)任一或任意几方面的用途:The expression control element according to claim 1, the nucleic acid construct according to claim 2, the vector according to claim 3 or the host cell according to claim 4 are in any one or any of the following aspects a)-e). the use of:
    a)调控基因表达,a) regulate gene expression,
    b)制备目标基因表达量提高的细胞,b) preparing cells with increased target gene expression,
    c)制备目标基因表达量提高的植物细胞、植物组织、植物部分或植物,c) preparing plant cells, plant tissues, plant parts or plants with increased expression of the target gene,
    d)制备提高基因表达的试剂或试剂盒,d) preparing a reagent or kit for enhancing gene expression,
    e)制备用于在植物细胞、植物组织或植物中提高目标基因表达量的试剂或试剂盒。e) Preparation of reagents or kits for increasing the expression level of target genes in plant cells, plant tissues or plants.
PCT/CN2021/126562 2020-10-28 2021-10-27 Expression regulatory element and use thereof WO2022089458A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202011172725.0 2020-10-28
CN202011172725.0A CN113564163A (en) 2020-10-28 2020-10-28 Expression regulation element and application thereof

Publications (1)

Publication Number Publication Date
WO2022089458A1 true WO2022089458A1 (en) 2022-05-05

Family

ID=78158794

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/126562 WO2022089458A1 (en) 2020-10-28 2021-10-27 Expression regulatory element and use thereof

Country Status (2)

Country Link
CN (1) CN113564163A (en)
WO (1) WO2022089458A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1063506A (en) * 1990-05-18 1992-08-12 卢布里绍尔遗传学股份有限公司 Be used for recombinant promoter in monocotyledons genetic expression
CN110709519A (en) * 2017-03-31 2020-01-17 先锋国际良种公司 Expression regulatory elements and uses thereof
WO2021178162A1 (en) * 2020-03-04 2021-09-10 Pioneer Hi-Bred International, Inc. Cis-acting regulatory elements

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2607489B1 (en) * 2008-04-07 2016-01-13 Monsanto Technology LLC Plant regulatory elements and uses thereof
BR112012008106A2 (en) * 2009-09-04 2019-08-20 Syngenta Participations Ag grouping of translational activating elements to increase polypeptide expression in plants
CA3064633C (en) * 2011-05-13 2023-01-31 Monsanto Technology Llc Plant regulaltory elements and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1063506A (en) * 1990-05-18 1992-08-12 卢布里绍尔遗传学股份有限公司 Be used for recombinant promoter in monocotyledons genetic expression
CN110709519A (en) * 2017-03-31 2020-01-17 先锋国际良种公司 Expression regulatory elements and uses thereof
WO2021178162A1 (en) * 2020-03-04 2021-09-10 Pioneer Hi-Bred International, Inc. Cis-acting regulatory elements

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J. G ELLIS, D. J LLEWELLYN, J. C WALKER, E. S DENNIS, W. J PEACOCK: "The ocs element: a 16 base pair palindrome essential for activity of the octopine synthase enhancer", THE EMBO JOURNAL, ENGLAND, 1 November 1987 (1987-11-01), England , pages 3203 - 3208, XP055479562, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC553770/pdf/emboj00251-0009.pdf> DOI: 10.1002/j.1460-2075.1987.tb02636.x *
KOUL B., YADAV R., SANYAL I., SAWANT S., SHARMA V., AMLA D.V.: "Cis-acting motifs in artificially synthesized expression cassette leads to enhanced transgene expression in tomato (Solanum lycopersicum L.)", PLANT PHYSIOLOGY AND BIOCHEMISTRY, ELSEVIER, AMSTERDAM, NL, vol. 61, 1 December 2012 (2012-12-01), AMSTERDAM, NL , pages 131 - 141, XP055927153, ISSN: 0981-9428, DOI: 10.1016/j.plaphy.2012.09.014 *

Also Published As

Publication number Publication date
CN113564163A (en) 2021-10-29

Similar Documents

Publication Publication Date Title
ES2655700T3 (en) Small RNAs in phase
US11873502B2 (en) Transgenic plants with enhanced traits
US20220145314A1 (en) Transgenic plants with enhanced traits
US20190127755A1 (en) Construct and vector for intragenic plant transformation
US20240102037A1 (en) Transgenic plants with enhanced traits
US20220380793A1 (en) Transgenic plants with enhanced traits
US20240002872A1 (en) Transgenic plants with enhanced traits
WO2022089458A1 (en) Expression regulatory element and use thereof
US10889828B2 (en) Transgenic plants with enhanced traits
WO2022166955A1 (en) Novel herbicide-resistant acetyl-coa carboxylase mutant and use thereof
WO2014164668A1 (en) Compositions of methods for increasing seed number, seed weight and/or yield in plants
US10487338B2 (en) Transgenic plants with enhanced traits
AU2018253628B2 (en) Construct and vector for intragenic plant transformation
WO2014084883A1 (en) Transgenic plants with enhanced traits
KR101219013B1 (en) Bottle gourds resistant to drought transformed with ABF3 gene and production method thereof
WO2013137490A1 (en) Polypeptide involved in morphogenesis and/or environmental stress resistance of plant
Agrawal et al. Anjana Rustagi, Garima Malik, Samira Chugh
KR20140058712A (en) Flower organ-specific apetala3a promoter derived from dendrobium
KR20140058713A (en) Flower organ-specific apetala3b promoter derived from dendrobium

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21885185

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21885185

Country of ref document: EP

Kind code of ref document: A1